<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Aging</journal-id><journal-id journal-id-type="iso-abbrev">Nat Aging</journal-id><journal-title-group><journal-title>Nature Aging</journal-title></journal-title-group><issn pub-type="epub">2662-8465</issn><publisher><publisher-name>Nature Publishing Group US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40307497</article-id><article-id pub-id-type="pmc">PMC12092250</article-id>
<article-id pub-id-type="publisher-id">855</article-id><article-id pub-id-type="doi">10.1038/s43587-025-00855-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8043-7314</contrib-id><name><surname>Soto-Heredero</surname><given-names>Gonzalo</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9715-8714</contrib-id><name><surname>Gaband&#x000e9;-Rodr&#x000ed;guez</surname><given-names>Enrique</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0817-1627</contrib-id><name><surname>Carrasco</surname><given-names>Elisa</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1538-8808</contrib-id><name><surname>Escrig-Larena</surname><given-names>Jos&#x000e9; Ignacio</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7447-694X</contrib-id><name><surname>G&#x000f3;mez de las Heras</surname><given-names>Manuel M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2055-6594</contrib-id><name><surname>Delgado-Pulido</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Francos-Quijorna</surname><given-names>Isaac</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5940-1827</contrib-id><name><surname>Blanco</surname><given-names>Eva M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0006-1483-4585</contrib-id><name><surname>Fern&#x000e1;ndez-Almeida</surname><given-names>&#x000c1;lvaro</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0401-7590</contrib-id><name><surname>Abia</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>Mar&#x000ed;a Josefa</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fern&#x000e1;ndez-D&#x000ed;az</surname><given-names>Cristina M.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0292-5010</contrib-id><name><surname>&#x000c1;lvarez-Flores</surname><given-names>Mar&#x000ed;a Beatriz</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Ram&#x000ed;rez de Molina</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Sascha</given-names></name><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9926-617X</contrib-id><name><surname>del Sol</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Zorita</surname><given-names>Virginia</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>S&#x000e1;nchez-Cabo</surname><given-names>F&#x000e1;tima</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8914-3400</contrib-id><name><surname>Torroja</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3487-8762</contrib-id><name><surname>Mittelbrunn</surname><given-names>Mar&#x000ed;a</given-names></name><address><email>mmittelbrunn@cbm.csic.es</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01cby8j38</institution-id><institution-id institution-id-type="GRID">grid.5515.4</institution-id><institution-id institution-id-type="ISNI">0000000119578126</institution-id><institution>Departamento de Biolog&#x000ed;a Molecular, Facultad de Ciencias, Centro de Biolog&#x000ed;a Molecular &#x02018;Severo Ochoa&#x02019;, </institution><institution>Universidad Aut&#x000f3;noma de Madrid, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01cby8j38</institution-id><institution-id institution-id-type="GRID">grid.5515.4</institution-id><institution-id institution-id-type="ISNI">0000000119578126</institution-id><institution>Consejo Superior de Investigaciones Cient&#x000ed;ficas, Centro de Biolog&#x000ed;a Molecular &#x02018;Severo Ochoa&#x02019;, </institution><institution>Universidad Aut&#x000f3;noma de Madrid, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01cby8j38</institution-id><institution-id institution-id-type="GRID">grid.5515.4</institution-id><institution-id institution-id-type="ISNI">0000000119578126</institution-id><institution>Departamento de Biolog&#x000ed;a, Facultad de Ciencias, Centro de Biolog&#x000ed;a Molecular &#x02018;Severo Ochoa&#x02019;, </institution><institution>Universidad Aut&#x000f3;noma de Madrid, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01cby8j38</institution-id><institution-id institution-id-type="GRID">grid.5515.4</institution-id><institution-id institution-id-type="ISNI">0000000119578126</institution-id><institution>Servicio de Microscop&#x000ed;a Electr&#x000f3;nica, Centro de Biolog&#x000ed;a Molecular &#x02018;Severo Ochoa&#x02019;, </institution><institution>Universidad Aut&#x000f3;noma de Madrid, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04g4ezh90</institution-id><institution-id institution-id-type="GRID">grid.482878.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0500 5302</institution-id><institution>IMDEA Food Institute, </institution><institution>CEI UAM+CSIC, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00ca2c886</institution-id><institution-id institution-id-type="GRID">grid.413448.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9314 1427</institution-id><institution>Centro Nacional de Investigaciones Cardiovasculares, </institution><institution>Instituto de Salud Carlos III, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/036x5ad56</institution-id><institution-id institution-id-type="GRID">grid.16008.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2295 9843</institution-id><institution>Luxembourg Centre for Systems Biomedicine, </institution><institution>University of Luxembourg, </institution></institution-wrap>Esch sur-Alzette, Luxembourg </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02x5c5y60</institution-id><institution-id institution-id-type="GRID">grid.420175.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0639 2420</institution-id><institution>CIC bioGUNE-BRTA (Basque Research and Technology Alliance), </institution><institution>Bizkaia Technology Park, </institution></institution-wrap>Derio, Spain </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01cc3fy72</institution-id><institution-id institution-id-type="GRID">grid.424810.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0467 2314</institution-id><institution>IKERBASQUE, Basque Foundation for Science, </institution></institution-wrap>Bilbao, Spain </aff></contrib-group><pub-date pub-type="epub"><day>30</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>5</volume><issue>5</issue><fpage>799</fpage><lpage>815</lpage><history><date date-type="received"><day>19</day><month>6</month><year>2023</year></date><date date-type="accepted"><day>27</day><month>3</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Recent studies using single-cell RNA sequencing technology have uncovered several subpopulations of CD4<sup>+</sup> T cells that accumulate with aging. These age-associated T cells are emerging as relevant players in the onset of inflammaging and tissue senescence. Here, based on information provided by single-cell RNA sequencing data, we present a flow cytometry panel that allows the identification of age-associated T cell subsets in systematic larger analysis in mice. We use this panel to evaluate at the single-cell level mitochondrial and senescence marks in the different age-associated CD4<sup>+</sup> T cell subpopulations. Our analysis identifies a subpopulation of regulatory T (T<sub>reg</sub>) cells that is characterized by the extracellular expression of the co-inhibitory molecule killer cell lectin-like receptor subfamily G member 1 (KLRG1) and accumulates with aging in humans and mice. KLRG1-expressing T<sub>reg</sub> cells display senescence features such as mitochondrial alterations, increased expression of cell-cycle regulators and genomic DNA damage. Functionally, KLRG1<sup>+</sup> T<sub>reg</sub> cells show a reduced suppressive activity in vivo accompanied by a pro-inflammatory phenotype.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">T cells undergo age-related changes that impair their organismal functions. Here Soto-Heredero et al. show that regulatory T cells characterized by the expression of KLRG1 accumulate with age in both mice and humans and exhibit features including mitochondrial decline and an inflammatory phenotype.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Lymphocytes</kwd><kwd>Senescence</kwd><kwd>Metabolism</kwd><kwd>Ageing</kwd><kwd>Inflammation</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100012818</institution-id><institution>Comunidad de Madrid</institution></institution-wrap></funding-source><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350; PIPF-2022/SAL-GL-25208</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><award-id>NutriSION-CM synergy grant Y2020/BIO-6350</award-id><principal-award-recipient><name><surname>Soto-Heredero</surname><given-names>Gonzalo</given-names></name><name><surname>Carrasco</surname><given-names>Elisa</given-names></name><name><surname>Escrig-Larena</surname><given-names>Jos&#x000e9; Ignacio</given-names></name><name><surname>G&#x000f3;mez de las Heras</surname><given-names>Manuel M.</given-names></name><name><surname>Delgado-Pulido</surname><given-names>Sandra</given-names></name><name><surname>Francos-Quijorna</surname><given-names>Isaac</given-names></name><name><surname>Blanco</surname><given-names>Eva M.</given-names></name><name><surname>Fern&#x000e1;ndez-Almeida</surname><given-names>&#x000c1;lvaro</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>Mar&#x000ed;a Josefa</given-names></name><name><surname>Fern&#x000e1;ndez-D&#x000ed;az</surname><given-names>Cristina M.</given-names></name><name><surname>Ram&#x000ed;rez de Molina</surname><given-names>Ana</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Universidad Aut&#x000f3;noma de Madrid - FPI-UAM</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100010663</institution-id><institution>EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)</institution></institution-wrap></funding-source><award-id>101044248-LetTBe</award-id><award-id>101044248-LetTBe</award-id><award-id>101044248-LetTBe</award-id><award-id>101044248-LetTBe</award-id><award-id>101044248-LetTBe</award-id><award-id>101044248-LetTBe</award-id><award-id>101044248-LetTBe</award-id><principal-award-recipient><name><surname>Carrasco</surname><given-names>Elisa</given-names></name><name><surname>Escrig-Larena</surname><given-names>Jos&#x000e9; Ignacio</given-names></name><name><surname>G&#x000f3;mez de las Heras</surname><given-names>Manuel M.</given-names></name><name><surname>Francos-Quijorna</surname><given-names>Isaac</given-names></name><name><surname>Blanco</surname><given-names>Eva M.</given-names></name><name><surname>Fern&#x000e1;ndez-Almeida</surname><given-names>&#x000c1;lvaro</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>Mar&#x000ed;a Josefa</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003339</institution-id><institution>Ministry of Economy and Competitiveness | Consejo Superior de Investigaciones Cient&#x000ed;ficas (Spanish National Research Council)</institution></institution-wrap></funding-source><award-id>PID2022-141169OB-I00; PID2022-138295OB-I00</award-id><award-id>PID2022-141169OB-I00; PID2022-138295OB-I00</award-id><award-id>PID2022-141169OB-I00; PID2022-138295OB-I00; FPU20/04066</award-id><award-id>PID2022-141169OB-I00; PID2022-138295OB-I00; FPU19/02576</award-id><award-id>PID2022-141169OB-I00; PID2022-138295OB-I00</award-id><award-id>PID2022-141169OB-I00; PID2022-138295OB-I00</award-id><award-id>PID2022-141169OB-I00; PID2022-138295OB-I00</award-id><award-id>PID2022-141169OB-I00; PID2022-138295OB-I00</award-id><principal-award-recipient><name><surname>Carrasco</surname><given-names>Elisa</given-names></name><name><surname>Escrig-Larena</surname><given-names>Jos&#x000e9; Ignacio</given-names></name><name><surname>G&#x000f3;mez de las Heras</surname><given-names>Manuel M.</given-names></name><name><surname>Delgado-Pulido</surname><given-names>Sandra</given-names></name><name><surname>Francos-Quijorna</surname><given-names>Isaac</given-names></name><name><surname>Blanco</surname><given-names>Eva M.</given-names></name><name><surname>Fern&#x000e1;ndez-Almeida</surname><given-names>&#x000c1;lvaro</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>Mar&#x000ed;a Josefa</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Universidad Aut&#x000f3;noma de Madrid - Juan de la Cierva IJC2018-036850-I</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Comunidad de Madrid and Universidad Aut&#x000f3;noma de Madrid - SI4/PJI/2024-00166</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature America, Inc. 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Main</title><p id="Par3">With age, the immune system loses the ability to respond to infections, cancer or vaccination. Instead, it engages in autoimmune and pro-inflammatory responses, which favor tissue damage and the acquisition of a low-grade systemic chronic inflammation, known as inflammaging, increasing the risk of many age-related diseases<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Thus, the decline of immune function during aging represents a major clinical challenge in many disease conditions including autoimmune diseases, infectious diseases, cancer and neurodegenerative and cardiovascular disorders<sup><xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref></sup>. The use of single-cell RNA sequencing (scRNA-seq) has allowed a deeper characterization of the different subsets of CD4<sup>+</sup> T cells that accumulate during aging. CD4<sup>+</sup> age-associated T cells (TAAs) include effector/memory T cells; a population of regulatory T (T<sub>reg</sub>) cells expressing activation genes (denoted as activated T<sub>reg</sub> cells or aT<sub>reg</sub> cells); cells with an exhaustion signature (denoted as exhausted); and cells overexpressing genes associated with cytotoxicity that have previously been described in the context of viral infections and cancer as CD4<sup>+</sup> cytotoxic T cells (denoted as cytotoxic)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p><p id="Par4">T<sub>reg</sub> cells, a subtype of CD4<sup>+</sup> T cells characterized by the expression of the forkhead box transcription factor (FOXP3), are required to maintain immune homeostasis and avoid excessive tissue damage preventing inflammatory and autoimmune diseases<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Understanding the molecular mechanisms behind age-associated changes in the T<sub>reg</sub> compartment is critical to understand the deterioration of the immune system during aging and the consequences for immunosenescence and inflammaging. T<sub>reg</sub> cells in aged mice are augmented in lymphoid organs (for example, spleen and lymph nodes)<sup><xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref></sup> and other nonlymphoid tissues such as the visceral fat and lungs<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, whereas they are reduced in muscle<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. T<sub>reg</sub> cells also undergo molecular changes with aging, becoming more dependent on IL-15 signaling owing to a lower expression of the IL-2 receptor CD25, while exhibiting enhanced levels of CD122 (IL-2/IL-15 receptor chain &#x003b2;)<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. Moreover, they acquire a memory-like profile during aging, characterized by the downregulation of CD62L and the upregulation of CD44 and CD69 (refs. <sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>). These aged effector&#x02013;memory T<sub>reg</sub> cells display increased expression of canonical pro-inflammatory transcription factors such as T-BET and ROR&#x003b3;T, and pro-inflammatory cytokines such as IFN-&#x003b3; or IL-17A<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. T<sub>reg</sub> cells with pro-inflammatory phenotypes have been denoted as fragile T<sub>reg</sub> cells in the context of cancer, although its function in antitumoral responses is still debated<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>.</p><p id="Par5">Killer cell lectin-like receptor subfamily G, member 1 (KLRG1) is a co-inhibitory receptor expressed by natural killer (NK) cells and antigen-experienced T cells. The expression of KLRG1 increases dramatically with age in human blood samples<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. In mice, KLRG1 has been used to identify memory precursor cells from effector T cells. In acute viral infection models, KLRG1 distinguishes short-lived effector CD8<sup>+</sup> T cells (KLRG1<sup>hi</sup>) and memory precursor effector CD8<sup>+</sup> T cells (KLRG1<sup>lo</sup>)<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. Importantly, KLRG1 identifies senescent CD8<sup>+</sup> T cells in humans and mice, as KLRG1<sup>+</sup>CD8<sup>+</sup> T cells exhibit reduced cytokine production and senescence characteristics such as a reduced proliferative capacity<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref></sup>. Regarding CD4<sup>+</sup> T cells, KLRG1 also identifies terminally differentiated cells<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Specifically in T<sub>reg</sub> cells, KLRG1 is considered a marker of effector suppressive T<sub>reg</sub> cells that display increased levels of activation markers (CD69, CD44, CD103 and CD39) and enhanced production of IL-10 (ref. <sup><xref ref-type="bibr" rid="CR26">26</xref></sup>).</p><p id="Par6">Mitochondria are the key controller of cellular metabolism, but also play a crucial role as signaling hubs for inflammation and cell death. Mitochondrial function declines with age in different cell types and tissues<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, including T cells<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>, affecting the mitochondrial ATP generation as well as reactive oxygen species (ROS) production and cellular signaling<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. In addition, mitochondrial dysfunction is sufficient to drive cellular senescence in fibroblasts<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. In contrast to conventional T cells, which engage glycolysis during immune response, T<sub>reg</sub> cells preferentially use mitochondrial respiration as source of ATP<sup><xref ref-type="bibr" rid="CR33">33</xref></sup> and the genetic induction of T<sub>reg</sub>-specific mitochondrial dysfunction leads to premature death by uncontrolled inflammation<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. Here, by using multiparametic spectral flow cytometry, we investigate the specific subpopulations of T cells that accumulate mitochondrial alterations during aging. Among them, we identify a population of T<sub>reg</sub> cells characterized by the expression of KLRG1 (kT<sub>reg</sub> cells) and FOXP3 that displays senescence features such as nuclear DNA damage. Although the suppressive capacity of kT<sub>reg</sub> cells is maintained in vitro, it is compromised in vivo. kT<sub>reg</sub> cells produce pro-inflammatory cytokines and, importantly, are also increased among human peripheral blood mononuclear cells (PBMCs) with age.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>T cells with mitochondrial alterations accumulate with aging</title><p id="Par7">To investigate age-associated mitochondrial dysfunction in T cells, we examined mitochondrial mass and mitochondrial membrane potential (MMP) by flow cytometry in circulating CD4<sup>+</sup> T cells from C57BL/6 mice at different ages ranging from 2 to 21&#x02009;months old by combining MitoTracker Green (MtG) and MitoTracker DeepRed (MtDR) staining. As a control, we used oligomycin that, by inhibiting the proton ATPase, increased the MMP and therefore the MtDR signal (Extended Data Fig. <xref rid="Fig9" ref-type="fig">1a</xref>). Both the MtG and MtDR signals declined during aging in circulating CD4<sup>+</sup> T cells (Extended Data Fig. <xref rid="Fig9" ref-type="fig">1b,c</xref>), suggesting that the proportion of T cells with mitochondrial alterations increases in aged mice (Fig. <xref rid="Fig1" ref-type="fig">1a,b</xref>). We obtained similar results using two additional mitochondrial probes: MitoTracker Red CM-X-ROS (Fig. <xref rid="Fig1" ref-type="fig">1c,d</xref>) and tetramethylrhodamine methyl ester (TMRM) (Extended Data Fig. <xref rid="Fig9" ref-type="fig">1d</xref>). Interestingly, MtG<sup>lo</sup>MtDR<sup>lo</sup> cells, which accumulate with aging, showed a reduced MtDR/MtG ratio, suggesting mitochondrial defects (Extended Data Fig. <xref rid="Fig9" ref-type="fig">1e</xref>). To confirm that MtG<sup>lo</sup>MtDR<sup>lo</sup> cells have altered mitochondria, we sorted MtG<sup>hi</sup>MtDR<sup>hi</sup> and MtG<sup>lo</sup>MtDR<sup>lo</sup> CD4<sup>+</sup> T cells from aged mice and performed electron microscopy (Fig. <xref rid="Fig1" ref-type="fig">1e,f</xref>). MtG<sup>lo</sup>MtDR<sup>lo</sup> cells showed an increased percentage of mitochondria with altered morphology<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> identified as round, small and with unstructured or even lost mitochondria cristae (Fig. <xref rid="Fig1" ref-type="fig">1f,g</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>CD4<sup>+</sup> T cells progressively accumulate altered mitochondria during aging.</title><p><bold>a</bold>,<bold>b</bold>, Representative flow cytometry plots showing the simultaneous analysis of MtG and MtDR (<bold>a</bold>) and the percentage of cells with MtG<sup>hi</sup>MtDR<sup>hi</sup>, MtG<sup>hi</sup>MtDR<sup>lo</sup> and MtG<sup>lo</sup>MtDR<sup>lo</sup> (<bold>b</bold>) in the circulating CD4<sup>+</sup> T cells from 2-month-old (<italic>n</italic>&#x02009;=&#x02009;5), 9-month-old (<italic>n</italic>&#x02009;=&#x02009;5), 13-month-old (<italic>n</italic>&#x02009;=&#x02009;5), 17-month-old (<italic>n</italic>&#x02009;=&#x02009;5) and 21-month-old (<italic>n</italic>&#x02009;=&#x02009;6) mice. <bold>c</bold>,<bold>d</bold>, Representative flow cytometry plots (<bold>c</bold>) and quantifications (<bold>d</bold>) of the simultaneous analysis of MtG and MitoTracker Red CMXROS in splenic CD4<sup>+</sup> T cells from young (2-month-old) and aged (21-month-old) mice. <bold>e</bold>, Representative flow cytometry plots showing the sorting strategy of MtG<sup>hi</sup>MtDR<sup>hi</sup> and MtG<sup>lo</sup>MtDR<sup>lo</sup> CD4<sup>+</sup> T cells from old mice. <bold>f</bold>,<bold>g</bold>, Representative images of electron microscopy (<bold>f</bold>) and quantifications (<bold>g</bold>) of healthy and morphologically altered mitochondria in MtG<sup>hi</sup>MtDR<sup>hi</sup> (green) and MtG<sup>lo</sup>MtDR<sup>lo</sup> (red) splenic CD4<sup>+</sup> T cells from old mice (<italic>n</italic>&#x02009;=&#x02009;90 and 300 cells from 2 different mice). <bold>h</bold>,<bold>i</bold>, Representative flow cytometry plots (<bold>h</bold>) and quantifications (<bold>i</bold>) of MtG<sup>hi</sup>MtDR<sup>hi</sup> and MtG<sup>lo</sup>MtDR<sup>lo</sup> cells in circulating naive (CD62L<sup>hi</sup>CD44<sup>lo</sup>, blue) and effector (CD62L<sup>lo</sup>CD44<sup>hi</sup>, purple) CD4<sup>+</sup> T cells from 2-, 9-, 13-, 17- and 21-month-old mice (<italic>n</italic>&#x02009;=&#x02009;6 mice per group). Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;s.e.m. Statistical analysis was performed using one-way ANOVA with with post hoc Tukey&#x02019;s correction (<bold>b</bold>), two-tailed unpaired Student&#x02019;s <italic>t</italic>-test (<bold>d</bold> and <bold>i</bold>: MtDR<sup>hi</sup>MtG<sup>hi</sup> 2 months, 9 months, 17 months, 21 months; MtDR<sup>lo</sup>MtG<sup>lo</sup> 2 months, 9 months, 21 months), two-tailed Welch&#x02019;s <italic>t</italic>-test (<bold>i</bold>: MtDR<sup>hi</sup>MtG<sup>hi</sup> 13 months; MtDR<sup>lo</sup>MtG<sup>lo</sup> 13 months, 17 months) or Mann&#x02013;Whitney <italic>U</italic> test (<bold>g</bold>). *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p><xref rid="MOESM3" ref-type="media">Source data</xref></p></caption><graphic xlink:href="43587_2025_855_Fig1_HTML" id="d33e917"/></fig></p><p id="Par8">Because the T cell subsets dramatically change with age and the most notable changes are the loss of naive T cell subsets and the increase in the effector memory pool<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, we assessed mitochondrial probes in na&#x000ef;ve (CD62L<sup>hi</sup>CD44<sup>lo</sup>) and effector&#x02013;memory (CD62L<sup>lo</sup>CD44<sup>hi</sup>) CD4<sup>+</sup> T cells in mice at different ages. We observed that, even in old mice, naive T cells were MtG<sup>hi</sup>MtDR<sup>hi</sup>, while effector&#x02013;memory cells were characterized by MtG<sup>lo</sup>MtDR<sup>lo</sup>, even in younger mice (Fig. <xref rid="Fig1" ref-type="fig">1h,i</xref>).</p></sec><sec id="Sec4"><title>KLRG1 identifies age-associated regulatory T cells</title><p id="Par9">To assess whether age-associated mitochondrial dysfunction equally affects all TAA subsets, we developed a multiparametric staining panel to identify the different age-associated CD4<sup>+</sup> T cell subsets. Our panel included surface markers based on gene expression of surface proteins identified by scRNA-seq<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>, complemented with known markers for immunosenescence, such as KLRG1 (ref. <sup><xref ref-type="bibr" rid="CR19">19</xref></sup>). In previous scRNA-seq experiments, splenic T cells from young mice were mainly classified as naive, naive_ISG15 and rT<sub>reg</sub> cells, whereas T cells from old mice were characterized by the accumulation of TAAs such as aT<sub>reg</sub>, effector memory T (T<sub>EM</sub>) cells, exhausted and cytotoxic T cells<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Unbiased clusterization of spectral flow cytometry analysis of splenic CD4<sup>+</sup> T cells from young (2-month-old) and old (21-month-old) mice resulted in seven subpopulations of T cells (Fig. <xref rid="Fig2" ref-type="fig">2a,b</xref>). Naive T cells were characterized by the expression of the adhesion molecule CD62L and the absence of the activation marker CD44. Three subsets of T<sub>reg</sub> cells were identified by the expression of CD25 and discriminated by different expression levels of CD62L, CD44 and KLRG1. The other CD4<sup>+</sup> T cell clusters presented marks of differentiation (CD62L<sup>lo</sup> and CD44<sup>hi</sup>) and were identified as cytotoxic based on the expression of NK-like markers, such as NKG2A and NKG2D, or as exhausted, based on the expression of classical exhaustion markers such as PD-1 and TIM3 (Fig. <xref rid="Fig2" ref-type="fig">2c,d</xref>). Young mice mostly displayed naive and rT<sub>reg</sub> cells, while aT<sub>reg</sub>, kT<sub>reg</sub>, T<sub>EM</sub>, cytotoxic and exhausted cells were increased in spleen from old mice (Fig. <xref rid="Fig2" ref-type="fig">2e,f</xref>). Importantly, this panel discriminated six out of the seven subpopulations previously defined by scRNA-seq analyses; however, because the panel is based on surface markers, we could not identify the ISG15_naive T cell subpopulation (Extended Data Fig. <xref rid="Fig10" ref-type="fig">2a,b</xref>). Our analysis identified a TAA subset characterized by the expression of KLRG1 (Fig. <xref rid="Fig2" ref-type="fig">2b</xref> and Extended Data Fig. <xref rid="Fig10" ref-type="fig">2a,b</xref>). In fact, circulating KLRG1<sup>+</sup> CD4<sup>+</sup> T cells progressively accumulated with aging (Extended Data Fig. <xref rid="Fig10" ref-type="fig">2c</xref>). Notably, these cells co-expressed KLRG1 and CD25, suggesting that KLRG1<sup>+</sup> CD4<sup>+</sup> T cells are probably a subpopulation of T<sub>reg</sub> cells (Fig. <xref rid="Fig2" ref-type="fig">2c,d</xref>). To confirm whether these CD25<sup>+</sup> KLRG1<sup>+</sup> cells were T<sub>reg</sub> cells, we combined the panel with the intracellular marker FOXP3 and we found that most of KLRG1<sup>+</sup> cells expressed CD25 and FOXP3 (83&#x02013;87%) (denoted as kT<sub>reg</sub> cells), supporting their T<sub>reg</sub> identity (Fig. <xref rid="Fig2" ref-type="fig">2g</xref>). The percentages of splenic kT<sub>reg</sub> cells assessed by spectral flow cytometry gradually increased with age within both the T<sub>reg</sub> compartment and CD4<sup>+</sup> T cells (Extended Data Fig. <xref rid="Fig10" ref-type="fig">2d,e</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Multiparametric spectral flow cytometry identifies a new age-associated T<sub>reg</sub> subset.</title><p><bold>a</bold>, UMAP representation of splenic CD4<sup>+</sup> T cells from young (left) and old mice (right) analyzed by spectral flow cytometry. <bold>b</bold>, UMAP with Cluster-X overlay showing the distribution of the different clusters of CD4<sup>+</sup> T cells identified by spectral flow cytometry (<italic>n</italic>&#x02009;=&#x02009;4 mice per group). <bold>c</bold>, UMAP representation of the expression levels of representative markers used to identify TAAs by flow cytometry. <bold>d</bold>, The distribution of the gMFI of representative markers used to identify TAAs in CD4<sup>+</sup> T cell subpopulations: naive (blue), rT<sub>reg</sub> (yellow), aT<sub>reg</sub> (orange), kT<sub>reg</sub> (red), T<sub>EM</sub> (light green), cytotoxic (brown) and exhausted (dark green) (<italic>n</italic>&#x02009;=&#x02009;4 mice per group). <bold>e</bold>,<bold>f</bold>, Representative pie charts (<bold>e</bold>) and box plots (<bold>f</bold>) comparing the percentage of cells belonging to each T cell subset in young (2-month-old, <italic>n</italic>&#x02009;=&#x02009;4) and old (22-month-old, <italic>n</italic>&#x02009;=&#x02009;5) mice. <bold>g</bold>, The gating strategy to identify FOXP3<sup>+</sup> cells within the kT<sub>reg</sub> cells in young (2-month-old) and old (22-month-old) mice (<italic>n</italic>&#x02009;=&#x02009;3 per group). gMFI, geometric mean fluorescence intensity. Each dot represents an individual mouse. Box-and-whisker plots show the median, the maximum, the minimum and the 25th and 75th percentiles. Statistical analysis was performed using two-tailed unpaired Student&#x02019;s <italic>t</italic>-test (<bold>f</bold>: naive) or two-tailed unpaired Welch&#x02019;s <italic>t</italic>-test (<bold>f</bold>: rT<sub>reg</sub>, aT<sub>reg</sub>, kT<sub>reg</sub>, T<sub>EM</sub>, exhausted and cytotoxic). *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p><xref rid="MOESM4" ref-type="media">Source data</xref></p></caption><graphic xlink:href="43587_2025_855_Fig2_HTML" id="d33e1168"/></fig></p><p id="Par10">In addition, we reanalyzed existing and publicly available scRNA-seq data from young and old mice to separate the novel kT<sub>reg</sub> cluster<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. By increasing the depth of the clusterization, we obtained an additional cluster, which accumulated during aging, within the aT<sub>reg</sub> subset (Extended Data Fig. <xref rid="Fig11" ref-type="fig">3a,b</xref>). Interestingly, the most determinant genes of this cluster were reminiscent of kT<sub>reg</sub> cells (Supplementary Table <xref rid="MOESM2" ref-type="media">1</xref>). These cells showed increased gene expression of <italic>Klrg1</italic> and altered expression of genes related to T<sub>reg</sub> function compared with aT<sub>reg</sub> cells, such as <italic>Icos</italic> and <italic>Maf</italic> (Extended Data Fig. <xref rid="Fig11" ref-type="fig">3c</xref>). We also found that kT<sub>reg</sub> cells expressed higher levels of inflammatory genes such as those belonging to the s100a family (including <italic>S100a4</italic>, <italic>S100a6</italic>, <italic>S100a10</italic>, <italic>S100a11</italic> and <italic>S100a13</italic>) and inflammation-related proteins such as galectins (<italic>Lgals1</italic> and <italic>Lgals9</italic>), IL-18 receptor (<italic>Il18r</italic>) and IFN-&#x003b3; receptor (<italic>Ifngr1</italic>) (Extended Data Fig. <xref rid="Fig11" ref-type="fig">3d</xref>).</p><p id="Par11">Then, we investigated the tissue distribution of kT<sub>reg</sub> cells. To map their preferential location in the different tissues, we used the multiparametric flow cytometry panel to analyze T cells from different tissues including spleen, bone marrow, liver, colonic lamina propria, white adipose tissue and Peyer&#x02019;s patches from young and old mice. kT<sub>reg</sub> cells were found in all these tissues (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>), and interestingly, the highest percentage of kT<sub>reg</sub> cells was observed in the colonic lamina propria (Fig. <xref rid="Fig3" ref-type="fig">3b,c</xref>). Importantly, the absolute numbers and the percentage of kT<sub>reg</sub> cells were increased in different tissues during aging (Fig. <xref rid="Fig3" ref-type="fig">3d</xref>) and their percentage was increased in spleen, bone marrow, liver and Peyer&#x02019;s patches but not in lamina propria and white adipose tissue (Fig. <xref rid="Fig3" ref-type="fig">3e</xref>). Altogether, we have developed a multiparametric flow cytometry method that allows the identification of TAA subsets in both lymphoid and nonlymphoid organs. Using this strategy, we have identified a subset of T<sub>reg</sub> cells characterized by the expression of KLRG1 that accumulates with aging.<fig id="Fig3"><label>Fig. 3</label><caption><title>kT<sub>reg</sub> cells accumulate peripheral tissues during aging and are preferentially located in the colonic lamina propria.</title><p><bold>a</bold>, UMAP with Cluster-X overlay showing the distribution of the different clusters of CD4<sup>+</sup> T cells from spleen, bone marrow, liver and colonic lamina propria of young mice analyzed by spectral flow cytometry. <bold>b</bold>, UMAP with Cluster-X overlay showing the distribution of the different clusters of CD4<sup>+</sup> T cells from young mice in different tissues (<italic>n</italic>&#x02009;=&#x02009;5). <bold>c</bold>, Representative bar plots showing the percentage of cells belonging to each T cell subset in spleen, bone marrow, liver and colonic lamina propria from young mice (<italic>n</italic>&#x02009;=&#x02009;5). <bold>d</bold>,<bold>e</bold>, Quantifications of absolute numbers of kT<sub>reg</sub> cells (<bold>d</bold>) and the percentage of kT<sub>reg</sub> cells among T<sub>reg</sub> cells (<bold>e</bold>) in different tissues in young (2-month-old, <italic>n</italic>&#x02009;=&#x02009;5) and old (22-month-old, <italic>n</italic>&#x02009;=&#x02009;4) mice. WAT, white adipose tissue. Box-and-whisker plots show the median, the maximum, the minimum and the 25th and 75th percentiles. Statistical analysis was performed using two-tailed unpaired Student&#x02019;s <italic>t</italic>-test (<bold>d</bold>: spleen and WAT; <bold>e</bold>: bone marrow, liver, lamina propria and WAT) or two-tailed Welch&#x02019;s <italic>t</italic>-test (<bold>d</bold>: bone marrow, lamina propria and Peyer&#x02019;s patches; <bold>e</bold>: spleen and Peyer&#x02019;s patches]. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p><xref rid="MOESM5" ref-type="media">Source data</xref></p></caption><graphic xlink:href="43587_2025_855_Fig3_HTML" id="d33e1356"/></fig></p></sec><sec id="Sec5"><title>KLRG1<sup>+</sup> T<sub>reg</sub> cells show mitochondrial alteration and senescence features</title><p id="Par12">To evaluate if any of the CD4<sup>+</sup> T cell subsets are more susceptible to the age-associated mitochondrial dysfunction, we combined our spectral flow cytometry panel together with the assessment of mitochondrial probes in young and old mice. Old CD4<sup>+</sup> T cells showed an increased proportion of MtG<sup>lo</sup>MtDR<sup>lo</sup> cells in all subsets compared with young CD4<sup>+</sup> T cells (Fig. <xref rid="Fig4" ref-type="fig">4a,b</xref>). Strikingly, even within the same mouse, there is a remarkable difference in the percentage of MtG<sup>lo</sup>MtDR<sup>lo</sup> in the distinct T cell subsets. While the naive cluster mainly exhibits low frequencies of MtG<sup>lo</sup>MtDR<sup>lo</sup> cells, T<sub>EM</sub> cells displayed the major accumulation of MtG<sup>lo</sup>MtDR<sup>lo</sup> cells in both young and old mice. Among T<sub>reg</sub> cells, kT<sub>reg</sub> cells showed an increased percentage of MtG<sup>lo</sup>MtDR<sup>lo</sup> cells compared with other T<sub>reg</sub> subsets in both young and old mice (Fig. <xref rid="Fig4" ref-type="fig">4a,c</xref>), suggesting that kT<sub>reg</sub> cells are terminally differentiated T<sub>reg</sub> cells with mitochondrial alterations.<fig id="Fig4"><label>Fig. 4</label><caption><title>TAAs have different predisposition to mitochondrial perturbations.</title><p><bold>a</bold>, Representative flow cytometry plots showing the simultaneous analysis of MtG and MtDR in the different subsets of CD4<sup>+</sup> T cells from 2- and 21-month-old mice: naive (blue), rT<sub>reg</sub> cells (yellow), aT<sub>reg</sub> cells (orange), kT<sub>reg</sub> cells (red), T<sub>EM</sub> (light green), cytotoxic (brown) and exhausted (dark green) (<italic>n</italic>&#x02009;=&#x02009;6 mice per group). <bold>b</bold>, A comparison of the percentage of MtG<sup>lo</sup>MtDR<sup>lo</sup> cells in each cluster of CD4<sup>+</sup> T cells in young (2-month-old) and old (21-month-old) mice (<italic>n</italic>&#x02009;=&#x02009;6 mice per group). <bold>c</bold>, A statistical comparison of the percentage of MtG<sup>lo</sup>MtDR<sup>lo</sup> cells in the different clusters in young or old mice (<italic>n</italic>&#x02009;=&#x02009;6 mice per group). Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;s.e.m. Box-and-whisker plots show the median, the maximum, the minimum and the 25th and 75th percentiles. Statistical analysis was performed using two-tailed unpaired Student&#x02019;s <italic>t</italic>-test (<bold>b</bold>: naive, rT<sub>reg</sub>, aT<sub>reg</sub> and T<sub>EM</sub>), Mann&#x02013;Whitney <italic>U</italic> test (<bold>b</bold>: kT<sub>reg</sub> and exhausted) or Friedman test with post hoc Dunn&#x02019;s correction (<bold>c</bold>). n.s., not significant; *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p><xref rid="MOESM6" ref-type="media">Source data</xref></p></caption><graphic xlink:href="43587_2025_855_Fig4_HTML" id="d33e1503"/></fig></p><p id="Par13">To better characterize the different T<sub>reg</sub> subpopulations, we compared the transcriptomic fingerprint of rT<sub>reg</sub>, aT<sub>reg</sub> and kT<sub>reg</sub> cells isolated from young (2-month-old) and old (26-month-old) mice by bulk RNA-seq. This transcriptomic dataset allowed us to improve the resolution of the kT<sub>reg</sub> cell expression profile. The clusterization grouped the samples by their identity rather than the age of the mice (Fig. <xref rid="Fig5" ref-type="fig">5a,b</xref>). We then analyzed the differentially expressed genes between the two age-associated T<sub>reg</sub> subsets, aT<sub>reg</sub> and kT<sub>reg</sub>. We found <italic>Klrg1</italic>, <italic>Il1rl1</italic> and <italic>Cd200r1</italic> as the most significantly increased genes in kT<sub>reg</sub> cells. Other genes upregulated in kT<sub>reg</sub> cells included <italic>Foxp3</italic>, <italic>Gata3</italic>, <italic>Ahr</italic>, NK-related genes (<italic>Klra8</italic>), granzymes (<italic>Gzmb</italic>, <italic>Gzma</italic> and <italic>Gzmc</italic>) and chemokine receptors (<italic>Ccr3</italic> and <italic>Ccr10</italic>) (Fig. <xref rid="Fig5" ref-type="fig">5c</xref>). The pathway analysis showed that kT<sub>reg</sub> cells exhibit increased expression of cellular senescence genes and P53 target genes, decreased expression of genes related to mitochondrial function and increased expression of inflammatory genes (Fig. <xref rid="Fig5" ref-type="fig">5d</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><title>KLRG1 identifies T<sub>reg</sub> cells with senescence features.</title><p><bold>a</bold>&#x02013;<bold>d</bold>, RNA sequencing of rT<sub>reg</sub>, aT<sub>reg</sub> and kT<sub>reg</sub> cells from young and old mice: PCA (<bold>a</bold>) and clusterization (<bold>b</bold>); volcano plot showing the DEGs between aT<sub>reg</sub> cells and kT<sub>reg</sub> cells (<bold>c</bold>); heat map of selected DEGs illustrating genes characteristic of identity, cellular senescence, P53 signaling, mitochondrial function and inflammation (<bold>d</bold>) (<italic>n</italic>&#x02009;=&#x02009;4 per group). <bold>e</bold>,<bold>f</bold>, Quantification of the expression of P16 (<bold>e</bold>) and P21 (<bold>f</bold>) by flow cytometry in splenic CD4<sup>+</sup> T cells from young (2&#x02009;months old, <italic>n</italic>&#x02009;=&#x02009;4) and old (21&#x02009;months old, <italic>n</italic>&#x02009;=&#x02009;3) mice measured as gMFI. <bold>g</bold>,<bold>h</bold>, Representative histograms and quantifications of the expression of P16 (<bold>g</bold>) and P21 (<bold>h</bold>) by flow cytometry in the different subsets of splenic T<sub>reg</sub> cells from young (<italic>n</italic>&#x02009;=&#x02009;4) and old (<italic>n</italic>&#x02009;=&#x02009;3) mice measured as gMFI: rT<sub>reg</sub> cells (yellow), aT<sub>reg</sub> cells (orange) and kT<sub>reg</sub> cells (red). <bold>i</bold>, Quantification of &#x003b3;H2AX gMFI in CD4<sup>+</sup> T cells from young and old mice (<italic>n</italic>&#x02009;=&#x02009;5 per group). <bold>j</bold>, Representative histogram and quantification of &#x003b3;H2AX by flow cytometry in the different subsets of T<sub>reg</sub> cells from young and old mice measured as gMFI (<italic>n</italic>&#x02009;=&#x02009;5 per group). gMFI values are relative to the gMFI in naive CD4<sup>+</sup> T cells. DEGs, differentially expressed genes; gMFI, geometric mean fluorescence intensity. Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;s.e.m. Statistical analysis between young and old mice was performed using two-tailed unpaired Student&#x02019;s <italic>t</italic>-test (<bold>e</bold>&#x02013;<bold>h</bold>: aT<sub>reg</sub>; <bold>i</bold> and <bold>j</bold>) or two-tailed Welch&#x02019;s <italic>t</italic>-test (<bold>h</bold>: rT<sub>reg</sub> and kT<sub>reg</sub>). Statistical analysis between subsets within the same animal was performed using RM one-way ANOVA with with post hoc Tukey&#x02019;s correction (<bold>g</bold>, <bold>h</bold> and <bold>j</bold>). Asterisks refers to statistic comparisons between rT<sub>reg</sub>, aT<sub>reg</sub> and kT<sub>reg</sub> in the same age group; the number signs refer to statistic comparisons between young and old mice. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p><xref rid="MOESM7" ref-type="media">Source data</xref></p></caption><graphic xlink:href="43587_2025_855_Fig5_HTML" id="d33e1751"/></fig></p><p id="Par14">Given that a mitochondrial dysfunction is a trigger of cellular senescence<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, and that the transcriptional fingerprint of kT<sub>reg</sub> cells showed increased expression of senescence-related genes, we interrogated whether kT<sub>reg</sub> cells display other features of cellular senescence beyond mitochondrial alterations. We analyzed the expression of the cell cycle regulators P16 and P21, which are increased in CD4<sup>+</sup> T cells during aging (Fig. <xref rid="Fig5" ref-type="fig">5e,f</xref>). We compared the three different subsets of T<sub>reg</sub> cells and found that kT<sub>reg</sub> cells displayed the highest expression of P16 and P21 (Fig. <xref rid="Fig5" ref-type="fig">5g,h</xref>). Moreover, as an additional marker of cellular senescence, we analyzed the genomic DNA damage measured as the phosphorylation of the histone H2AX in the serine 139 (&#x003b3;H2AX), a marker of DNA double strand breaks that is increased in CD4<sup>+</sup> T cells from old mice (Fig. <xref rid="Fig5" ref-type="fig">5i</xref>). Interestingly, kT<sub>reg</sub> cells also displayed increased DNA damage compared with aT<sub>reg</sub> cells (Fig. <xref rid="Fig5" ref-type="fig">5j</xref>).</p></sec><sec id="Sec6"><title>KLRG1<sup>+</sup> T<sub>reg</sub> cells express ST2 and are induced by IL-33 in vivo</title><p id="Par15">In light of the increased expression of <italic>Gata3</italic> in kT<sub>reg</sub> cells (Fig. <xref rid="Fig5" ref-type="fig">5c</xref>), and to further characterize the kT<sub>reg</sub> subset, we compared the expression of different transcription factors related to T cell function by flow cytometry. This analysis revealed that kT<sub>reg</sub> cells expressed higher levels of FOXP3 compared with the other T<sub>reg</sub> subsets (Fig. <xref rid="Fig6" ref-type="fig">6a</xref> and Extended Data Fig. <xref rid="Fig12" ref-type="fig">4</xref>), whereas the levels of ROR&#x003b3;T and T-BET were similar to aT<sub>reg</sub> cells. Importantly, kT<sub>reg</sub> cells expressed higher levels of GATA3 than aT<sub>reg</sub> cells in both young and old mice (Fig. <xref rid="Fig6" ref-type="fig">6a</xref> and Extended Data Fig. <xref rid="Fig12" ref-type="fig">4</xref>), supporting the RNA-seq results. TOX and MAF expression was higher in kT<sub>reg</sub> cells compared with rT<sub>reg</sub> and aT<sub>reg</sub> cells, but this difference was not observed in old mice (Fig. <xref rid="Fig6" ref-type="fig">6a</xref> and Extended Data Fig. <xref rid="Fig12" ref-type="fig">4</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><title>KLRG1<sup>+</sup> T<sub>reg</sub> differentiation depends on the IL-33&#x02013;ST2 axis.</title><p><bold>a</bold>, Representative histograms and quantifications of the expression of different transcription factors by flow cytometry in splenic rT<sub>reg</sub> (yellow), aT<sub>reg</sub> (orange) and kT<sub>reg</sub> (red) cells from old (21-month-old) mice measured as gMFI (<italic>n</italic>&#x02009;=&#x02009;6 mice per group). gMFI values are relative to the MFI in rT<sub>reg</sub> cells (<italic>n</italic>&#x02009;=&#x02009;6 per group). <bold>b</bold>, Representative histograms and quantifications of ST2 expression by flow cytometry in the different clusters of splenic CD4<sup>+</sup> T cells from young (2-month-old) and old (21-month-old) mice: naive (blue), rT<sub>reg</sub> (yellow), aT<sub>reg</sub> (orange), kT<sub>reg</sub> (red), T<sub>EM</sub> (light green), cytotoxic (brown) and exhausted (dark green) cells measured as gMFI (<italic>n</italic>&#x02009;=&#x02009;6 mice per group). <bold>c</bold>&#x02013;<bold>g</bold>, In vivo differentiation of kT<sub>reg</sub> cells: young control mice (2&#x02009;months old) were treated with IL-2&#x02009;+&#x02009;IL-33 or NaCl for 6&#x02009;days and analyzed on day 7 after injection (<italic>n</italic>&#x02009;=&#x02009;3 mice per group) (<bold>c</bold>); representative flow cytometry plot and quantification of the proportion of splenic T<sub>reg</sub> cells in young mice treated with NaCl or IL-2 and IL-33 (<bold>d</bold>); representative flow cytometry plot and quantification of the proportion of KLRG1<sup>+</sup> T<sub>reg</sub> cells in young mice treated with NaCl or IL-2 and IL-33 (<bold>e</bold>); quantification of the absolute numbers of KLRG1<sup>+</sup> T<sub>reg</sub> cells in young mice treated or not treated with IL-2 and IL-33 (<italic>n</italic>&#x02009;=&#x02009;3 mice per group) (<bold>f</bold>); quantification of the percentage of each T<sub>reg</sub> cluster in young mice treated with NaCl or IL-2 and IL-33 (<italic>n</italic>&#x02009;=&#x02009;3 mice per group) (<bold>g</bold>). gMFI, geometric mean fluorescence intensity. Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;s.e.m. Box-and-whisker plots show the median, the maximum, the minimum and the 25th and 75th percentiles. Statistical analysis was performed using Friedman test with post hoc Dunn&#x02019;s correction (<bold>a</bold> and <bold>b</bold>: old), RM one-way ANOVA with post hoc Tukey&#x02019;s correction (<bold>b</bold>: young), two-tailed unpaired Student&#x02019;s <italic>t</italic>-test (<bold>d</bold>, <bold>e</bold> and <bold>g</bold>) or two-tailed Welch&#x02019;s <italic>t</italic>-test (<bold>f</bold>). *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p><xref rid="MOESM8" ref-type="media">Source data</xref></p></caption><graphic xlink:href="43587_2025_855_Fig6_HTML" id="d33e1985"/></fig></p><p id="Par16">GATA3 is essential for the regulatory function of T<sub>reg</sub> cells<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. Given that GATA3-expressing T<sub>reg</sub> cells are characterized by the expression of the IL-33 receptor ST2 (refs. <sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>), we analyzed the expression of ST2 in the different CD4<sup>+</sup> T cell clusters. We observed that kT<sub>reg</sub> cells expressed higher levels of ST2 than the rest of T cell subsets in both young and old mice (Fig. <xref rid="Fig6" ref-type="fig">6b</xref>). Based on that, we tried to induce the differentiation of kT<sub>reg</sub> cells in vivo by administration of IL-33 in young mice. Before IL-33 administration, we injected IL-2, which induces the expansion of T<sub>reg</sub> cells due to their expression of the IL-2 receptor CD25 (ref. <sup><xref ref-type="bibr" rid="CR43">43</xref></sup>) (Fig. <xref rid="Fig6" ref-type="fig">6c</xref>). Upon this treatment, we found an expansion of T<sub>reg</sub> cells in the injected mice (Fig. <xref rid="Fig6" ref-type="fig">6c</xref>) and an increase in the percentage and absolute number of kT<sub>reg</sub> cells (Fig. <xref rid="Fig6" ref-type="fig">6e,f</xref>). Interestingly, this treatment seems to induce the differentiation of aT<sub>reg</sub> cells into kT<sub>reg</sub> cells (Fig. <xref rid="Fig6" ref-type="fig">6g</xref>), suggesting that kT<sub>reg</sub> cells rely on ST2&#x02013;IL-33 signaling for differentiation.</p></sec><sec id="Sec7"><title>KLRG1<sup>+</sup> T<sub>reg</sub> cells exhibit a pro-inflammatory phenotype</title><p id="Par17">To investigate the function of kT<sub>reg</sub> cells, we analyzed the suppressive function of these cells both in vitro and in vivo. First, we isolated T<sub>reg</sub> cells from old mice, sorted them on the basis of KLRG1 expression and co-cultured them with naive T cells loaded with CellTrace Violet at a 1:2 ratio (1 T<sub>reg</sub>:2 naive). Both KLRG1<sup>+</sup> and KLGR1<sup>&#x02212;</sup> T<sub>reg</sub> cells showed a similar suppressive capacity in vitro (Extended Data Fig. <xref rid="Fig13" ref-type="fig">5a,b</xref>). Next, we performed an in vivo suppression assay by injecting naive CD45.1 CD4<sup>+</sup> T cells alone or in combination with CD45.2 KLRG1<sup>&#x02212;</sup> or KLRG1<sup>+</sup> T<sub>reg</sub> cells into T cell-deficient mice (CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> CD45.2) (Fig. <xref rid="Fig7" ref-type="fig">7a</xref>). While KLRG1<sup>&#x02212;</sup> T<sub>reg</sub> cells were able to restrain the weight loss induced by naive T cells, mice injected with naive T cells together with KLRG1<sup>+</sup> T<sub>reg</sub> cells lost weight to a similar extent as mice exclusively injected with naive T cells (Fig. <xref rid="Fig7" ref-type="fig">7b</xref>). Four months after the adoptive transfer, CD45.1 cells were more abundant in mice injected with KLRG1<sup>+</sup> T<sub>reg</sub> cells (Fig. <xref rid="Fig7" ref-type="fig">7c</xref>). In addition, we found that transferred CD45.1 CD4<sup>+</sup> T cells were more activated when co-transferred with KLRG1<sup>+</sup> T<sub>reg</sub> cells, as shown by their increased expression of CCL5 and PD-1, than when co-transferred with KLRG1<sup>&#x02212;</sup> T<sub>reg</sub> cells (Fig. <xref rid="Fig7" ref-type="fig">7d</xref>). Importantly, we observed an increased prevalence of fibrotic colon and fecal blood in mice injected with naive T cells alone or together with KLRG1<sup>+</sup> T<sub>reg</sub> cells than in mice injected with naive T cells together with KLRG1<sup>&#x02212;</sup> T<sub>reg</sub> cells (Fig. <xref rid="Fig7" ref-type="fig">7e,f</xref>). Altogether, these data suggest that the function and/or viability of KLRG1<sup>+</sup> T<sub>reg</sub> cells in vivo is compromised.<fig id="Fig7"><label>Fig. 7</label><caption><title>Analysis of the suppressive and pro-inflammatory function of KLRG1<sup>+</sup> T<sub>reg</sub> cells.</title><p><bold>a</bold>&#x02013;<bold>f</bold>, In vivo assessment of the suppressive activity of KLRG1<sup>+</sup> T<sub>reg</sub> cells. CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> T cell-deficient mice were exclusively injected with naive CD45.1 CD4<sup>+</sup> T cells (<italic>n</italic>&#x02009;=&#x02009;4) or in combination with either CD45.2 KLRG1<sup>&#x02212;</sup> T<sub>reg</sub> cells (<italic>n</italic>&#x02009;=&#x02009;5) or CD45.2 KLRG1<sup>+</sup> T<sub>reg</sub> cells (<italic>n</italic>&#x02009;=&#x02009;5) isolated from young mice treated with IL-2&#x02009;+&#x02009;IL-33. Noninjected CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> (<italic>n</italic>&#x02009;=&#x02009;3) are represented for the sake of comparison. The injected mice were monitored for 4&#x02009;months and analyzed. <bold>a</bold>, Schematic diagram depicting the in vivo suppression assay. <bold>b</bold>, The body weight of CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> mice injected with naive CD4<sup>+</sup> T cells alone or in combination with KLRG1<sup>&#x02212;</sup> or KLRG1<sup>+</sup> T<sub>reg</sub> cells. The weight of each animal was normalized to its own weight before the inoculation. <bold>c</bold>, The percentage of transferred CD45.1 naive (striped color) or CD45.2 T<sub>reg</sub> (flat color) cells analyzed by flow cytometry in CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> mice injected with naive and/or T<sub>reg</sub> cells. <bold>d</bold>, Quantification of the expression of CCL5 and PD-1 by flow cytometry in the injected CD45.1 CD4<sup>+</sup> T cells measured as gMFI. <bold>e</bold>,<bold>f</bold>, The percentage of mice with fibrotic colon (<bold>e</bold>) or fecal blood (<bold>f</bold>) in mice injected with naive and/or T<sub>reg</sub> cells. <bold>g</bold>, Representative histograms and quantifications of the expression of different cytokines by flow cytometry in splenic rT<sub>reg</sub> (yellow), aT<sub>reg</sub> (orange) and kT<sub>reg</sub> (red) cells from old (21-month-old) mice measured as gMFI. gMFI values are relative to the MFI in rT<sub>reg</sub> cells (<italic>n</italic>&#x02009;=&#x02009;6). <bold>h</bold>,<bold>i</bold>, Analysis of the secretion of different cytokines by the T<sub>reg</sub> subsets using multiplex. T<sub>reg</sub> subsets were sorted from young mice injected with IL-2&#x02009;+&#x02009;IL-33 and incubated during 24&#x02009;h in 10% FBS complete RPMI medium before the assay (<italic>n</italic>&#x02009;=&#x02009;3). Heat map (<bold>h</bold>) and statistical comparisons of the secretion of different cytokines by rT<sub>reg</sub>, aT<sub>reg</sub> and kT<sub>reg</sub> cells. Heat map values are relative to the maximum of each cytokine. Quantification (<bold>i</bold>) of SASP-related cytokines secreted by rT<sub>reg</sub>, aT<sub>reg</sub> and kT<sub>reg</sub> cells. gMFI, geometric mean fluorescence intensity. Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;s.e.m. Statistical analysis was performed using one-way ANOVA with post hoc Tukey&#x02019;s correction (<bold>c</bold>: CD45.1; <bold>d</bold> and <bold>e</bold>), Krukal&#x02013;Wallis test with post hoc Dunn&#x02019;s correction (<bold>c</bold>: CD45.2), Friedman test with post hoc Dunn&#x02019;s correction (<bold>g</bold>&#x02013;<bold>i</bold>). n.s., not significant; *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p><xref rid="MOESM9" ref-type="media">Source data</xref></p></caption><graphic xlink:href="43587_2025_855_Fig7_HTML" id="d33e2317"/></fig></p><p id="Par18">To further explore the activity of kT<sub>reg</sub> cells, we assessed their capacity to produce cytokines by ex vivo intracellular flow cytometry. We found that kT<sub>reg</sub> cells from old mice expressed higher amounts of the anti-inflammatory cytokine IL-10 than the rest of the T<sub>reg</sub> subsets (Fig. <xref rid="Fig7" ref-type="fig">7g</xref>). We found no differences in the production of IL-17 or IFN-&#x003b3; by kT<sub>reg</sub> cells compared with aT<sub>reg</sub> cells, but kT<sub>reg</sub> cells produced more TNF (Fig. <xref rid="Fig7" ref-type="fig">7g</xref>). Similar results were observed when comparing T<sub>reg</sub> subsets from young mice (Extended Data Fig. <xref rid="Fig13" ref-type="fig">5c</xref>). Furthermore, we measured the cytokine secretion of the different T<sub>reg</sub> subsets. We induced kT<sub>reg</sub> expansion in vivo by IL-33 administration and sorted rT<sub>reg</sub>, aT<sub>reg</sub> and kT<sub>reg</sub> cells. After 24&#x02009;h in vitro, we assessed the cytokine release by multiplex analysis of the culture media and we observed that, in agreement with our flow cytometry data, kT<sub>reg</sub> cells secreted higher amounts of IL-10 together with pro-inflammatory cytokines than the other T<sub>reg</sub> subsets (Fig. <xref rid="Fig7" ref-type="fig">7h</xref>). Notably, kT<sub>reg</sub> cells produced higher levels of senescence-associated secretory phenotype (SASP)-related factors including IL-1&#x003b2;, IL-6, IL-13, IFN-&#x003b3;, GM-CSF, CXCL2, CXCL1, CCL1 and CCL3 than rT<sub>reg</sub> or aT<sub>reg</sub> cells (Fig. <xref rid="Fig7" ref-type="fig">7i</xref>). Noteworthy, upon activation, aT<sub>reg</sub> cells secreted similar or even higher levels of most cytokines than kT<sub>reg</sub> cells. However, kT<sub>reg</sub> cells maintained increased production of IL-10, IL-6, GM-CSF and CXCL2 (Extended Data Fig. <xref rid="Fig13" ref-type="fig">5d,e</xref>). Finally, to investigate the function of kT<sub>reg</sub> cells in vivo, we adoptively transferred KLRG1<sup>&#x02212;</sup> and KLRG1<sup>+</sup> T<sub>reg</sub> cells into CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> mice (Extended Data Fig. <xref rid="Fig13" ref-type="fig">5f</xref>). In agreement with the increased production of pro-inflammatory cytokines, we found that mice transferred with KLRG1<sup>+</sup> T<sub>reg</sub> cells showed splenomegaly together with increased percentages of circulating neutrophils and basophils compared with noninjected or mice injected with KLRG1<sup>&#x02212;</sup> T<sub>reg</sub> cells (Extended Data Fig. <xref rid="Fig13" ref-type="fig">5g,h</xref>).</p></sec><sec id="Sec8"><title>KLRG1<sup>+</sup> T<sub>reg</sub> cells increase in human blood samples during aging</title><p id="Par19">We wondered whether the kT<sub>reg</sub> population is also increased in humans during aging. We used flow cytometry to analyze the presence of kT<sub>reg</sub> cells in PBMCs from a human cohort of 144 healthy volunteers separated into two groups: young (ranging from 18 to 25&#x02009;years old) and senior (over 55&#x02009;years old) (see Extended Data Fig. <xref rid="Fig14" ref-type="fig">6</xref> for the gating strategy). We found an increased frequency of kTregs in the senior population (14.56% of T<sub>reg</sub> cells) compared with young individuals (6.35% of T<sub>reg</sub> cells) (Fig. <xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig8"><label>Fig. 8</label><caption><title>KLRG1<sup>+</sup> T<sub>reg</sub> cells are increased in human blood during aging.</title><p><bold>a</bold>, Representative flow cytometry plots of the gating of KLRG1<sup>+</sup> T<sub>reg</sub> cells in PBMCs samples from young and senior volunteers. <bold>b</bold>&#x02013;<bold>d</bold>, Quantifications of the percentage of KLRG1<sup>+</sup> T<sub>reg</sub> cells among T<sub>reg</sub> cells (<bold>b</bold>), among CD4<sup>+</sup> cells (<bold>c</bold>) and among total lymphocytes (<bold>d</bold>) in young (18&#x02013;25&#x02009;years old, <italic>n</italic>&#x02009;=&#x02009;42) and senior (&#x02265;55&#x02009;years old, <italic>n</italic>&#x02009;=&#x02009;75) individuals by flow cytometry. Each dot represents an individual. Data are presented as mean values&#x02009;&#x000b1;&#x02009;s.e.m. Statistical analysis was performed using two-tailed unpaired Welch&#x02019;s <italic>t</italic>-test (<bold>b</bold>) or Mann&#x02013;Whitney <italic>U</italic> test (<bold>c</bold> and <bold>d</bold>). *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p><xref rid="MOESM10" ref-type="media">Source data</xref></p></caption><graphic xlink:href="43587_2025_855_Fig8_HTML" id="d33e2516"/></fig></p><p id="Par20">Altogether, by using deep flow cytometry analysis, we have identified a subset of T<sub>reg</sub> cells characterized by the expression of KLRG1 and ST2. Besides typical T<sub>reg</sub> cytokines such as IL-10, kT<sub>reg</sub> cells produce other SASP-related cytokines and chemokines such as IL-1&#x003b2;, IL-6, IL-13, IFN-&#x003b3;, GM-CSF, CXCL2, CXCL1, CCL1 and CCL3. kT<sub>reg</sub> cells also harbor senescence features such as mitochondrial decline, expression of cell cycle inhibitors and DNA damage. These kT<sub>reg</sub> cells with senescence features are induced in response to IL-33 and accumulate with aging in different tissues, but they are especially abundant in the gut in mice. Importantly, circulating kT<sub>reg</sub> cells are increased in humans during aging.</p></sec></sec><sec id="Sec9" sec-type="discussion"><title>Discussion</title><p id="Par21">T cells play a critical role in recognizing and depleting damage or infected cells and sustaining tissue homeostasis preventing inflammation and tissue deterioration<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. However, like every cell type in the body, T cells undergo changes as they age, leading to diminished function and compromising tissue homeostasis. Recently, scRNA-seq technology has enabled the decoding of the heterogeneity of age-associated CD4<sup>+</sup> and CD8<sup>+</sup> T cells that accumulate over time<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>. Using this information, we have developed a multiparametric panel of 20 antibodies, which allows routine discrimination of T cell heterogeneity during aging by spectral flow cytometry. With this strategy, we have mapped the different TAAs that accumulate during aging in different tissues and we have identified KLRG1-expressing T<sub>reg</sub> cells as a subset accumulating in blood, lymphoid and nonlymphoid tissues during natural aging and harboring aging features, including mitochondrial alterations.</p><p id="Par22">Functional T<sub>reg</sub> cells are essential to restore tissue homeostasis and to prevent autoimmunity and inflammation. Although it is well established that T<sub>reg</sub> cells are augmented in several organs during aging in both humans and mice, whether their function is compromised with aging is still a matter of debate. Some authors showed that young and old T<sub>reg</sub> cells have equivalent suppressive capacity<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>, whereas others showed an age-related increase in T<sub>reg</sub> function linked to increased risk of malignancies and infections in older adults<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. By contrast, there is also evidence of a deterioration of T<sub>reg</sub> function during aging. Old T<sub>reg</sub> cells are not able to suppress IL-17<sup>+</sup> T cells upon chronic inflammation<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, failing to control hypersensitivity<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> and producing reduced amounts of IL-10 (ref. <sup><xref ref-type="bibr" rid="CR47">47</xref></sup>).</p><p id="Par23">KLRG1 is a marker of highly differentiated T cells, and it has been considered as a marker of immunosenescence<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. In addition, a subset of terminally differentiated T<sub>reg</sub> cells that express KLRG1 has been identified as short-lived T<sub>reg</sub> cells expressing higher levels of suppressive (that is, CTLA-4 and IL-10) but also inflammatory molecules<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> located in nonlymphoid barriers, metabolic tissues or at sites of inflammation<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. For example, KLRG1<sup>+</sup> T<sub>reg</sub> cells contribute to insulin resistance<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> and IFN-&#x003b3;- and IL-10-secreting KLRG1<sup>+</sup> T<sub>reg</sub> cells also infiltrate the central nervous system during experimental autoimmune encephalomyelitis<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Using our flow cytometry panel, we mapped the presence of kT<sub>reg</sub> cells in different tissues including spleen, bone marrow, liver, colonic lamina propria, white adipose tissue, Peyer&#x02019;s patches and blood during aging. Our results demonstrate that kT<sub>reg</sub> cells increase during aging in most of the analyzed tissues and that the colonic lamina propria is a preferential location for kT<sub>reg</sub> cells, reaching 50% of the total T<sub>reg</sub> pool. Importantly, T<sub>reg</sub> cells are critical for gut homeostasis<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>, which is essential for healthy aging.</p><p id="Par24">Our results also support that kT<sub>reg</sub> cells express the IL-33 receptor ST2 and that their differentiation depends on IL-33. IL-33 is an interleukin-1-like cytokine that plays a critical role in mucosal immunity, favoring Th2 differentiation<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. IL-33 is increased in the adipose tissue with aging<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>, and it induces thymic involution and T cell dysfunction<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Further research is required to define whether IL-33 levels change in lymphoid tissues or in the circulation during aging or if the differentiation of kT<sub>reg</sub> cells depends on other factors.</p><p id="Par25">By combining the multiparametric panel with mitochondrial probes, we assessed which of the different T cell subsets that accumulate during aging show mitochondrial dysfunction. We found that, whereas naive T cells are MtG<sup>hi</sup>MtDR<sup>hi</sup>, even in old mice, TAAs show increased percentage of cells with low MtG and MtDR stainings. Within T<sub>reg</sub> cells, we found that kT<sub>reg</sub> cells show higher percentage of MtG<sup>lo</sup>MtDR<sup>lo</sup>, indicating that they harbor reduced mitochondrial mass and MMP. The MMP is an important indicator of mitochondrial integrity and function. During the mitochondrial respiration, electrons are ejected from the mitochondrial matrix to the intermembrane space to generate an electrochemical gradient. An optimal MMP is required for most of the mitochondrial functions including the generation of ATP, the uptake of ions, the synthesis of iron&#x02013;sulfur clusters and others. When the MMP is not recovered, unpolarized mitochondria are degraded by mitophagy<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. The simultaneous assessment of mitochondrial mass and MMP by flow cytometry have been extensively used to characterize the health status of mitochondria in different tissues, including T cells, under different conditions such as tumor environment<sup><xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR60">60</xref></sup>. Nevertheless, changes in the molecular composition of mitochondria, particularly in cardiolipins, lead to a reduction in the binding of MitoTracker probes in intraepithelial lymphocytes that, besides their low signal of MtG and MtDR, showed a similar mitochondria number on electron microscopy images<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. Importantly, a reduction in the staining of these probes could also be explained by changes in the plasma membrane potential or by the expression of multidrug resistance transporters that expel the fluorescent probes<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. To confirm that the changes that we observed in MtG and MDR stating are related to mitochondria, we sorted MtG<sup>hi</sup>MtDR<sup>hi</sup> and MtG<sup>lo</sup>MtDR<sup>lo</sup> CD4<sup>+</sup> T cells and assessed mitochondrial morphology by electron microscopy. Electron microscopy analysis shows that MtG<sup>lo</sup>MtDR<sup>lo</sup> cells have mitochondrial changes including signs of cristae remodeling, supporting that MtG<sup>lo</sup>MtDR<sup>lo</sup> T cells have mitochondrial alterations. However, additional research is needed to determine whether the MtG<sup>lo</sup>MtDR<sup>lo</sup> T cell population also has structural or biochemical changes in the composition of mitochondria, in the plasma membrane potential and/or in the expression of multidrug transporters that could explain the dramatic reduction in MtG and MtDR staining. Importantly, beyond the key role of mitochondrial metabolism for the suppressive function of T<sub>reg</sub> cells<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>, a proper mitochondrial metabolism of T<sub>reg</sub> cells is essential for maintaining liver homeostasis during aging. Deleting Altre, a long noncoding RNA found in T<sub>reg</sub> cells and upregulated with aging, leads to mitochondrial dysfunction, causing liver inflammation, fibrosis and cancer in aged mice<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Therefore, the increase in kT<sub>reg</sub> cells with impaired mitochondria could be detrimental with aging. However, the function of kT<sub>reg</sub> cells during aging and age-associated diseases requires further exploration.</p><p id="Par26">Our findings demonstrate that, besides mitochondrial alterations, kT<sub>reg</sub> cells harbor other signs of senescence. A recent study found that T<sub>reg</sub> cells undergo senescence faster than conventional T cells through a ROS-dependent mechanism<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. In addition, both mitochondrial decline and cellular senescence are tightly interconnected<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. An important number of senescent-associated changes are dependent on mitochondrial function, especially the pro-inflammatory phenotype. Therefore, the pro-inflammatory phenotype observed in kT<sub>reg</sub> cells could be a consequence of their mitochondrial dysfunction. The mitochondrial damage leads to the release of mitochondrial DNA (mtDNA) to the cytosol. mtDNA fragments trigger the activation of the cGAS&#x02013;STING pathway, leading to the production of type I interferons, such as IFN-&#x003b2;, and pro-inflammatory cytokines, such as TNF or IL-6 (ref. <sup><xref ref-type="bibr" rid="CR65">65</xref></sup>), which are part of the SASP<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. Cytosolic mtDNA, especially the oxidized mtDNA, also activates NLRP3 promoting the assembly of the inflammasome, a structure that leads to the activation of caspase I, therefore leading to the release of active IL-18 and IL-1&#x003b2; by the pyroptotic cell death<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. As kT<sub>reg</sub> cells harbor mitochondrial damage, they could also experience a release of mtDNA that would trigger their pro-inflammatory phenotype. Moreover, the mitochondrial dysfunction also contributes to lysosomal stress favoring a pro-inflammatory phenotype in CD4<sup>+</sup> T cells<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>.</p><p id="Par27">Surprisingly, there is recent evidence supporting the idea that senescence could be a reversible state. Chemotherapy-induced senescent cells can be released from senescence and reenter into the cell cycle<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. In addition, tissue senescence can be transitorily induced to promote tissue regeneration in <italic>Hydractinia symbiolongicarpus</italic><sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. Regarding CD4<sup>+</sup> T cells, a recent study demonstrated that the expression of the senescence marker KLRG1 is transient in a subset of resident T<sub>reg</sub> cells, despite their maintenance of an activated phenotype<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. Because the specific ablation of mitochondria from senescent cells is sufficient to reverse many features of the senescent phenotype<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>, mitochondria are a promising target for interventions aimed at reducing the harmful effects of senescence in aging tissues. Interestingly, mitochondria dysfunction in exhausted CD8<sup>+</sup> T cells can be reversed by scavenging ROS or boosting mitochondrial function with nicotinamide riboside<sup><xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR73">73</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup>, suggesting that mitochondrial stress is reversible and that mitochondria could be key to restoring T cell function. Future research should clarify whether mitochondrial damage and other features of senescence are targetable in kT<sub>reg</sub> cells.</p><p id="Par28">Sustaining a proper function of T cells during aging is essential for healthy aging. Unraveling the changes in different T cell compartments will help to better understand the underlying mechanisms of age-associated immunological decline and, thus, to develop therapeutic interventions that enhance immunity in older adults.</p></sec><sec id="Sec10"><title>Methods</title><sec id="Sec11"><title>Animal procedures</title><p id="Par29">C57BL/6J HccRsd mice were purchased from Envigo or generated at the Centro de Biolog&#x000ed;a Molecular Severo Ochoa (Madrid, Spain) animal facilities. All mice required for this study were bred and aged in specific-pathogen-free conditions in the animal facility of Centro de Biolog&#x000ed;a Molecular Severo Ochoa (Madrid, Spain). All mice were housed in ventilated cages within animal rooms maintained under a 12&#x02009;h&#x02013;12&#x02009;h light-dark cycle. Animal rooms were temperature and humidity controlled. Standard diet and water were available ad libitum. Both male and female mice were used in this study.</p><p id="Par30">All the procedures with animals were previously evaluated and approved (PROEX 287/16 and PROEX 52.1/23) by the ethics commitee on animal experimentation of the CBMSO, the authorized commitee of the Spanish National Research Council or the Universidad Aut&#x000f3;noma de Madrid, and the regional government (Comunidad de Madrid). All mice were checked for any macroscopic abnormalities (according to the Jackson guide &#x02018;AGED C57BL/6J MICE FOR RESEARCH STUDIES&#x02019;). Mice were used at different ages: young (less than 4&#x02009;months of age), adult (4&#x02013;20&#x02009;months of age) and old (over 20&#x02009;months of age).</p><p id="Par31">CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> mice (JAX stock no. 004177) were kindly provided by Prof. B. Alarc&#x000f3;n (CBM). CD45.1 (JAX stock no. 002014) mice were kindly provided by Dr. C. Cobaleda (CBM). Both strains were in C57BL/7 background.</p><sec id="Sec12"><title>IL-2 + IL-33 treatment</title><p id="Par32">The IL-2 immune complex was prepared as previously described<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. In brief, 1&#x02009;&#x000b5;g of IL-2 (Peprotech, #212-12) was mixed with 5&#x02009;&#x000b5;g of &#x003b1;-IL-2 (BioLegend, #503706) per mouse and incubated at room temperature (RT) for 30&#x02009;min. Each mouse was intraperitoneally injected for three consecutive days. As a control, mice received only 200&#x02009;&#x003bc;l of NaCl 0.9%. From the third day, IL-2 was combined with IL-33. 1&#x02009;&#x000b5;g of IL-33 (BioLegend, #580506) was injected in 200&#x02009;&#x003bc;l of NaCl per mouse for five consecutive days. As a control, mice received only 200&#x02009;&#x003bc;l of NaCl.</p></sec><sec id="Sec13"><title>Adoptive transfer of T<sub>reg</sub> cells</title><p id="Par33">For the study of the function of kT<sub>reg</sub> cells in vivo, KLRG1<sup>&#x02212;</sup> and KLRG1<sup>+</sup> T<sub>reg</sub> cells (CD4<sup>+</sup>CD25<sup>+</sup>) were isolated by fluorescence-activated cell sorting (FACS) from IL-33-treated mice and injected into CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> young mice for three consecutive days. Approximately 8&#x02009;&#x000d7;&#x02009;10<sup>5</sup> total T<sub>reg</sub> cells were injected per mouse. Mice were weighed and monitored every 3&#x02009;days for 4&#x02009;months after the adoptive transfer and then were euthanized and the spleens were analyzed.</p></sec></sec><sec id="Sec14"><title>Suppression assays</title><p id="Par34">For the in vivo suppression assays, KLRG1<sup>&#x02212;</sup> and KLRG1<sup>+</sup> T<sub>reg</sub> cells (CD4<sup>+</sup>CD25<sup>+</sup>) were isolated by FACS from IL-33-treated mice. Naive CD4<sup>+</sup> T cells were purified by magnetic isolation (Stemcell Technologies, #19765) from young CD45.1 mice. A total of 6&#x02009;&#x000d7;&#x02009;10<sup>5</sup> naive CD4<sup>+</sup> T cells alone or in combination with 1.5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> KLRG1<sup>&#x02212;</sup> or KLRG1<sup>+</sup> T<sub>reg</sub> cells were intravenously injected into CD3&#x003b5;<sup>&#x02212;/&#x02212;</sup> young mice. The animals were weighed and monitored every 3&#x02009;days for 4&#x02009;months after the adoptive transfer and then were euthanized and the colonic lamina propria was analyzed.</p><p id="Par35">For the in vitro suppression assays, KLRG1<sup>&#x02212;</sup> and KLRG1<sup>+</sup> T<sub>reg</sub> cells (CD4<sup>+</sup>CD25<sup>+</sup>) were isolated by FACS from old mice. Naive CD4<sup>+</sup> T cells were purified by magnetic isolation from young CD45.1 mice. CD45.1<sup>+</sup> naive CD4<sup>+</sup> T cells were labeled with 1&#x02009;&#x000b5;M of CellTrace Violet (Invitrogen, C34571) in PBS for 30&#x02009;min at 37&#x02009;&#x000b0;C. A total of 2.5&#x02009;&#x000d7;&#x02009;10<sup>4</sup> naive T<sub>reg</sub> cells were incubated with 1.25 T<sub>reg</sub> cells for 3&#x02009;days. Cells were stimulated with Mouse T-Activator Dynabeads (Gibco, 11452D) following the manufacturer&#x02019;s instructions. The percentage of suppression was determined as follows: 100&#x02009;&#x02212;&#x02009;(% of proliferating cells with T<sub>reg</sub> cells)/(% of proliferating cells without T<sub>reg</sub> cells).</p></sec><sec id="Sec15"><title>Human samples</title><p id="Par36">Volunteer recruitment was performed through the GENYAL Clinical Trials Platform of IMDEA Alimentaci&#x000f3;n (Madrid, Spain). This study was approved by the institutional Research Ethics Committee (IMDEA Food Foundation, IMD PI-052 and IMD PI-055) and performed in accordance with the principles of research involving human subjects stated in the Declaration of Helsinki (1964). All patients were clearly informed about the study methodology and provided written informed consent.</p><p id="Par37">Peripheral blood samples were collected from a total of 117 volunteers belonging to two different population groups, whose inclusion criteria were as follows:<list list-type="bullet"><list-item><p id="Par38">Young healthy population (<italic>n</italic>&#x02009;=&#x02009;42): 14 male and 28 female healthy volunteers aged between 18 and 25&#x02009;years.</p></list-item><list-item><p id="Par39">Senior population (<italic>n</italic>&#x02009;=&#x02009;75): 28 male and 47 female volunteers over 55&#x02009;years of age.</p></list-item></list>Exclusion criteria were common for both study groups and included: decreased cognitive function, pregnancy or breastfeeding, severe chronic health conditions (for example, chronic kidney, liver and heart disease), immunodeficiencies and autoimmune diseases, and immunosuppressive or psychotropic pharmacological treatment. The results shown in the study apply to both sexes. The experimental groups have been defined by the age or the participants, and no sex- and gender-based analyses have been performed. Volunteers received financial compensation after the study.</p></sec><sec id="Sec16"><title>Tissue processing for flow cytometry</title><p id="Par40">Mice were euthanized with CO<sub>2</sub> followed by perfusion with cold PBS. The indicated tissues were extracted and processed as specified.</p><sec id="Sec17"><title>Spleen and lymph nodes</title><p id="Par41">Lymph nodes were collected from inguinal, mesenteric, cervical and axillar areas. Spleen and lymph nodes were mashed and filtered through a 70-&#x003bc;m cell strainer. The cell suspension was centrifuged at 300<italic>g</italic> for 5&#x02009;min at 4&#x02009;&#x000b0;C. Red blood cells were removed using 5&#x02009;ml of erythrocyte lysis buffer (ammonium chloride 0.15&#x02009;M, sodium bicarbonate 0.01&#x02009;M and EDTA 0.0001&#x02009;M) for 5&#x02009;min. Cells were washed, centrifuged, resuspended and counted.</p></sec><sec id="Sec18"><title>Blood</title><p id="Par42">Blood was extracted from either the facial vein or the heart in living or euthanized mice, respectively. The cell suspension was centrifuged at 300<italic>g</italic> for 5&#x02009;min at 4&#x02009;&#x000b0;C. Red blood cells were removed resuspending the cells in 5&#x02009;ml of erythrocyte lysis buffer for 5&#x02009;min. Cells were washed, centrifuged, resuspended and stained.</p></sec><sec id="Sec19"><title>Colonic lamina propria</title><p id="Par43">T cells from colonic lamina propria were isolated as previously reported<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. Colon samples between the cecum and rectum were obtained and cleaned from fat and feces. Tissues were cut longitudinally, washed with cold PBS and then cut transversally into 1-cm-long fragments, mixed in prewarmed 5&#x02009;mM EDTA, 14&#x02009;mH HEPES, 10% FBS PBS and incubated under shaking at 180&#x02009;rpm for 30&#x02009;min at 37&#x02009;&#x000b0;C. After washing with PBS, tissue pieces were then minced and mixed in prewarmed 25&#x02009;mM HEPES, 10% FBS RPMI supplemented with 300&#x02009;U&#x02009;ml<sup>&#x02212;1</sup> collagenase type VIII (Sigma, C2139) under shaking at 180&#x02009;rpm for 45&#x02009;min at 37&#x02009;&#x000b0;C. The digested tissue was filtered through a 70-&#x003bc;m cell strainer, washed with 5&#x02009;mM EDTA, 14&#x02009;mH HEPES, 10% FBS PBS and centrifuged at 650<italic>g</italic> for 5&#x02009;min at RT. To further enrich in leukocytes, supernatants were centrifuged in a 40%/70% Percoll gradient (Sigma, GE17-0891-01) at 750<italic>g</italic> for 20&#x02009;min at RT with minimum acceleration and without brake. Isolated cells were washed with PBS and resuspended in 2% FBS RPMI for counting.</p></sec><sec id="Sec20"><title>White adipose tissue</title><p id="Par44">Gonadal white adipose tissue was obtained from the mouse abdominal cavity and mixed in 2&#x02009;mg&#x02009;ml<sup>&#x02212;1</sup> BSA, 2% FBS RPMI supplemented with 2&#x02009;mg&#x02009;ml<sup>&#x02212;1</sup> collagenase type II (Sigma, C6885) under shaking at 180&#x02009;rpm for 40&#x02009;min at 37&#x02009;&#x000b0;C. The digested tissue was vertically rested to separate fat from the aqueous phases, which were obtained using an 18&#x02009;G syringe. Then, the cell suspensions were filtered through a 70-&#x003bc;m cell strainer and washed with 2% FBS RPMI. Finally, erythrocytes were removed by incubation with a lysis buffer for 5&#x02009;min at 4&#x02009;&#x000b0;C, washed with 1&#x02009;mM EDTA PBS and finally resuspended in 1&#x02009;ml of 1&#x02009;mM EDTA 2% FBS PBS for counting.</p></sec><sec id="Sec21"><title>Peyer&#x02019;s patches</title><p id="Par45">Peyer&#x02019;s patches were collected from the intestine and mashed into a 70-&#x003bc;m cell strainer. The cell suspension was centrifuged at 400<italic>g</italic> for 5&#x02009;min at 4&#x02009;&#x000b0;C. Finally, the cell pellets were resuspended in 1&#x02009;ml of 2% FBS RPMI for counting.</p></sec><sec id="Sec22"><title>Liver</title><p id="Par46">Liver was collected and cut into prewarmed 25&#x02009;mM HEPES, 10% FBS RPMI supplemented with 0.4&#x02009;mg&#x02009;ml<sup>&#x02212;1</sup> collagenase type VIII (Sigma, C2139) under shaking at 180&#x02009;rpm for 45&#x02009;min at 37&#x02009;&#x000b0;C. Digested tissue was filtered through a 70-&#x003bc;m cell strainer and centrifuged at 350<italic>g</italic> for 5&#x02009;min at 4&#x02009;&#x000b0;C. Red blood cells were removed using 5&#x02009;ml of erythrocyte lysis buffer for 5&#x02009;min. To further enrich in leukocytes, supernatants were centrifuged in a 40%/70% Percoll gradient (Sigma, GE17-0891-01) at 1,250<italic>g</italic> for 30&#x02009;min at RT with acceleration on 6 and without brake. Isolated cells were washed with PBS and resuspended in ml 2% FBS RPMI for counting.</p></sec><sec id="Sec23"><title>Bone marrow</title><p id="Par47">Femurs and tibias were collected and the cells from the bone marrow were obtained by centrifuging the bones at 6,000<italic>g</italic> for 1&#x02009;min. Red blood cells were removed using 5&#x02009;ml of erythrocyte lysis buffer for 5&#x02009;min. Cells were washed and resuspended in 2% FBS PBS for counting.</p></sec><sec id="Sec24"><title>Human samples</title><p id="Par48">Human blood samples were collected by venipuncture in an overnight fasting state. Three milliliters of blood were collected in TransFix/EDTA vacuum blood collection tubes (Cytomark) and preserved until the day of staining and cell acquisition.</p></sec></sec><sec id="Sec25"><title>Flow cytometry</title><p id="Par49">To differentiate between live and dead, the cells were first stained with the Zombie NIR Fixable Viability Kit (BioLegend, 423106, 1:3,000), the Zombie Yellow Fixable Viability Kit (BioLegend, 423104, 1:3,000) or the Ghost Dye Violet 540 (Tonbo Biosciences, 13-0879, 1:3,000) for 20&#x02009;min at 4&#x02009;&#x000b0;C. Then, the cells were washed with FACS staining buffer (PBS supplemented with 2% fetal bovine serum and 1&#x02009;mM EDTA) and incubated with Fc receptor blocker purified rat anti-mouse anti-CD16/CD32 (BD Biosciences, 553142, 1:200) for 20&#x02009;min at 4&#x02009;&#x000b0;C. Cells were then incubated with primary antibodies for 20&#x02009;min at 4&#x02009;&#x000b0;C and were washed twice with FACS staining buffer. The following antibodies were diluted in Brilliant Stain Buffer (BD Biosciences, 566349) for surface antigen staining:<table-wrap id="Taba"><table frame="hsides" rules="groups"><thead><tr><th>Antigen</th><th>Fluorochrome</th><th>Dilution</th><th>Clone</th><th>Supplier</th><th>Catalog</th></tr></thead><tbody><tr><td>CD38</td><td>Pacific Blue</td><td>1:500</td><td>90</td><td>BioLegend</td><td>102720</td></tr><tr><td>TIM3</td><td>BV480</td><td>1:200</td><td>5D12/TIM-3</td><td>BD Biosciences</td><td>747618</td></tr><tr><td>CD244.2 (2B4)</td><td>BV510</td><td>1:200</td><td>2B4</td><td>BD Biosciences</td><td>740115</td></tr><tr><td>CD44</td><td>BV570</td><td>1:200</td><td>IM7</td><td>BioLegend</td><td>103037</td></tr><tr><td>CD69</td><td>BV650</td><td>1:100</td><td>H1.2F3</td><td>BioLegend</td><td>104541</td></tr><tr><td>CD62L</td><td>BV711</td><td>1:400</td><td>MEL-14</td><td>BioLegend</td><td>104445</td></tr><tr><td>CD95</td><td>BV750</td><td>1:100</td><td>Jo2</td><td>BD Biosciences</td><td>747413</td></tr><tr><td>KLRG1</td><td>BV785</td><td>1:200</td><td>2F1</td><td>BioLegend</td><td>138429</td></tr><tr><td>CD223 (LAG3)</td><td>BB515</td><td>1:200</td><td>C9B7W</td><td>BD Biosciences</td><td>566210</td></tr><tr><td>CD49d</td><td>PerCP-Cy5.5</td><td>1:100</td><td>R1-2</td><td>BioLegend</td><td>103619</td></tr><tr><td>PD-1</td><td>PerCP-eFluor710</td><td>1:200</td><td>J43</td><td>ThermoFisher</td><td>46-9985-80</td></tr><tr><td>ST2</td><td>PerCP-eFluor710</td><td>1:200</td><td>RMST2-33</td><td>ThermoFisher</td><td>46-9333-82</td></tr><tr><td>NKG2A</td><td>PE</td><td>1:200</td><td>16A11</td><td>BioLegend</td><td>142804</td></tr><tr><td>NKG2D</td><td>PE-Dazzle594</td><td>1:200</td><td>CX5</td><td>BioLegend</td><td>130214</td></tr><tr><td>CD25</td><td>PE Cy5</td><td>1:400</td><td>PC61</td><td>BioLegend</td><td>102007</td></tr><tr><td>CD8</td><td>PE-Fire700</td><td>1:1000</td><td>53-6.7</td><td>BioLegend</td><td>100792</td></tr><tr><td>CD28</td><td>APC</td><td>1:50</td><td>E18</td><td>BioLegend</td><td>122016</td></tr><tr><td>CD153</td><td>R718</td><td>1:200</td><td>RM153</td><td>BD Biosciences</td><td>751871</td></tr><tr><td>CD27</td><td>APC-Cy7</td><td>1:400</td><td>LG.3A10</td><td>BioLegend</td><td>124226</td></tr><tr><td>CD4</td><td>APC-Fire810</td><td>1:1000</td><td>Gk1.5</td><td>BioLegend</td><td>100480</td></tr></tbody></table></table-wrap></p><p id="Par50">For intracellular staining, after staining for membrane markers, the cells were fixed and permeabilized using the FOXP3/Transcription Factor Staining Kit (eBioscience, 00-5523-00) for 20&#x02009;min at RT and darkness. To assess cytokine production, cells were stimulated for 4&#x02009;h with 50&#x02009;ng&#x02009;ml<sup>&#x02212;1</sup> phorbol 12-myristate 13-acetate (PMA) (ThermoFisher, 356150010) and 1&#x02009;&#x003bc;g&#x02009;ml<sup>&#x02212;1</sup> ionomycin (Tocris, 1704) in the presence of brefeldin A (eBiosciences, 00-4506-51). Cells were then stained the following intracellular antibodies:<table-wrap id="Tabb"><table frame="hsides" rules="groups"><thead><tr><th>Antibody</th><th>Fluorochrome</th><th>Dilution</th><th>Clone</th><th>Supplier</th><th>Catalog</th></tr></thead><tbody><tr><td>IL-10</td><td>Pacific Blue</td><td>1:100</td><td>JES5-16E3</td><td>BioLegend</td><td>505020</td></tr><tr><td>IL-17</td><td>PE</td><td>1:100</td><td>TC11-18H10.1</td><td>BioLegend</td><td>506904</td></tr><tr><td>TNF</td><td>APC</td><td>1:100</td><td>MP6-XT22</td><td>BioLegend</td><td>506308</td></tr><tr><td>IFN-&#x003b3;</td><td>Spark NIR 685</td><td>1:100</td><td>XMG1.2</td><td>BioLegend</td><td>505861</td></tr><tr><td>MAF</td><td>eFluor450</td><td>1:100</td><td>sym0F1</td><td>ThermoFisher</td><td>48-9855-41</td></tr><tr><td>FOXP3</td><td>FITC</td><td>1:200</td><td>FJK-165</td><td>ThermoFisher</td><td>11-5773-82</td></tr><tr><td>ROR&#x003b3;t</td><td>PE</td><td>1:100</td><td>Q31-378</td><td>BD Biosciences</td><td>562607</td></tr><tr><td>T-BET</td><td>AlexaFluor594</td><td>1:100</td><td>4B10</td><td>BioLegend</td><td>644834</td></tr><tr><td>T-BET</td><td>APC</td><td>1:100</td><td>4B10</td><td>BioLegend</td><td>17-5825-82</td></tr><tr><td>TOX</td><td>eFluor660</td><td>1:200</td><td>TXRX10</td><td>ThermoFisher</td><td>50-6502-80</td></tr><tr><td>&#x003b3;H2AX</td><td>&#x02013;</td><td>1:300</td><td>20E3</td><td>CellSignaling</td><td>9718</td></tr><tr><td>P16</td><td>&#x02013;</td><td>1:200</td><td>Polyclonal</td><td>ThermoFisher</td><td>PA5-119712</td></tr><tr><td>P21</td><td>Alexa Fluor 647</td><td>1:400</td><td>Polyclonal</td><td>Abcam</td><td>ab237265</td></tr><tr><td>Donkey anti-rabbit</td><td>Alexa Fluor 647</td><td>1:500</td><td>Polyclonal</td><td>ThermoFisher</td><td>A-31573</td></tr></tbody></table></table-wrap></p><p id="Par51">All flow cytometry experiments from mouse samples were performed with four-laser (violet, blue, yellow-green and red) or five-laser Aurora analyzers (Cytek Biosciences). Data were analyzed with the FlowJo v10.5.3 software (BD Biosciences). Gating strategies were set on the basis of fluorescence minus one controls, unstained samples and unstimulated samples (when needed). All the samples in the experiment excluded dead cells, clumps and debris.</p><p id="Par52">In human samples, each tube contained at least 2&#x02009;&#x000d7;&#x02009;10<sup>6</sup> human whole blood cells. Cells were labeled by incubation with appropriate fluorescence-conjugated antibodies for 15&#x02009;min at RT in the dark. Cells were then lysed with 2&#x02009;ml of FACS lysing solution (BD Biosciences) for 10&#x02009;min and centrifuged at 500<italic>g</italic> for 5&#x02009;min at RT. Then, the cells were washed with 5&#x02009;ml of PBS. The following antibodies were used for surface antigen staining:<table-wrap id="Tabc"><table frame="hsides" rules="groups"><thead><tr><th>Antibody</th><th>Fluorochrome</th><th>Dilution</th><th>Clone</th><th>Supplier</th><th>Catalog</th></tr></thead><tbody><tr><td>CD8</td><td>BUV496</td><td>1:100</td><td>RPA-T8</td><td>BD Biosciences</td><td>612942</td></tr><tr><td>CD25</td><td>BUV615</td><td>1:100</td><td>2A3</td><td>BD Biosciences</td><td>612996</td></tr><tr><td>CD19</td><td>BUV661</td><td>1:100</td><td>1D3</td><td>BD Biosciences</td><td>612971</td></tr><tr><td>CD45</td><td>BV510</td><td>1:100</td><td>HI30</td><td>BD Biosciences</td><td>563204</td></tr><tr><td>CD4</td><td>BV786</td><td>1:100</td><td>SK3</td><td>BD Biosciences</td><td>664528</td></tr><tr><td>CD127</td><td>PE</td><td>1:100</td><td>HIL-7R-M21</td><td>BD Biosciences</td><td>561028</td></tr><tr><td>CD3</td><td>APC</td><td>1:100</td><td>HIT3a</td><td>BD Biosciences</td><td>555342</td></tr><tr><td>KLRG1</td><td>APC-Cy7</td><td>1:100</td><td>2F1/KLRG1</td><td>BioLegend</td><td>138426</td></tr></tbody></table></table-wrap></p><p id="Par53">Experiments with human samples were performed in a BD FACSymphony A5 SORP flow cytometer (BD Biosciences). To generate comparable results among patients and over time, the photomultiplier voltages were adjusted to unlabeled lysed whole blood cells to obtain optimal photomultiplier tube voltages for the resolution of dim cell populations. The target values resulting of the optimization were used for subsequent calibrations to maintain instrument standardization. When possible, at least 40,000 events of CD4 population were acquired to reach the maximum T<sub>reg</sub> events. Data were analyzed using the FlowJoTM v.10 software.</p><p id="Par54">The gating strategy for identifying kT<sub>reg</sub> cells is illustrated in the Extended Data Fig. <xref rid="Fig14" ref-type="fig">6</xref>. In brief, first, doublets and debris were excluded in forward scatter (FSC) &#x02013; side scatter (SSC) dot plots. Then, a region in CD45 and SSC parameters were used to discriminate leukocytes. Next, lymphocytes were gated in a SSC &#x02013; CD4 dot plot. Lymphoid cells were further cleaned in a SSC &#x02013; CD45 plot. After that, CD3<sup>+</sup>CD19<sup>&#x02212;</sup> T cells were gated and, among them, CD4<sup>+</sup> T lymphocytes were distinguished. The T<sub>reg</sub> cells were identified, within the CD4<sup>+</sup> T cells, by gating the CD25<sup>hi</sup>CD27<sup>lo</sup> population. Then, the expression of KLRG1 was analyzed in T<sub>reg</sub> cells. To have a negative control to properly gate KLRG1<sup>+</sup> cells, the gate was established in B cells.</p><sec id="Sec26"><title>Analysis of mitochondrial fitness</title><p id="Par55">Analysis of mitochondrial mass and MMP was performed by flow cytometry in cells labeled for 30&#x02009;min with 50&#x02009;nM MitoTracker Green FM (Invitrogen, M7514), 200&#x02009;nM MitoTracker DeepRed FM (Invitrogen, M22426), 40&#x02009;nM Image-iT TMRM (Invitrogen, I34361) or 50&#x02009;nM MitoTracker Red CMXRos (Invitrogen, M7512) in RPMI medium with no FBS in a 37&#x02009;&#x000b0;C and 5% CO<sub>2</sub> incubator before extracellular staining. After incubation, cells were washed with FACS staining buffer and incubated with antibodies for extracellular staining.</p></sec></sec><sec id="Sec27"><title>Dimensional reduction and clustering analysis of flow cytometry data</title><p id="Par56">Dimensional reduction and clustering analysis of flow cytometry data was done using OMIQ (Dotmatics). First, nonlymphocyte cells, doublets and dead cells were excluded on the basis of viability staining and FSC and SSC parameters. Then, 15,000 CD4<sup>+</sup> cells from each sample were subsampled for further analysis. For dimensional reduction, the Uniform Manifold Approximation and Projection (UMAP) algorithm was applied with the following parameters: neighbors = 15, minimum distance = 0.4, components = 2, learning rate = 1, epochs = 200. For unbiased clustering, the Cluster-X algorithm was applied with alpha = 0.001. Mean fluorescence intensity for each marker projected on the UMAP plots was used to infer the cluster&#x02019;s identity, and similar clusters were combined.</p></sec><sec id="Sec28"><title>RNA-seq</title><p id="Par57">rT<sub>reg</sub>, aT<sub>reg</sub> and kT<sub>reg</sub> cells were isolated from young and old mice by FACS. RNA was extracted with the RNeasy Micro Kit (Qiagen, 74004) following manufacturer&#x02019;s instructions. Sample quality was measured using the Qubit 3.0 fluorimeter for sample concentration and Agilent 5400 for fragment analysis. SMART-Seq V4 Ultra Low Input RNA kit for Sequencing 480 Rxns (Takarabio, 634893) was used for efficient cDNA synthesis and library preparation. After amplification, cDNA was purified using AMPure XP beads (Beckman Coulter, A63882) to remove any contaminants and ensure high-quality cDNA. The library was checked with Qubit and real-time PCR for quantification and bioanalyzer for size distribution detection. Quantified libraries were pooled and sequenced on Illumina Illumina Novaseq X plus using a PE150 (pair-end 150 base pair) strategy to produce 6G of data.Fastq files quality check was performed using FastQC v0.11.9. RNA-seq reads were mapped to the <italic>Mus musculus</italic> reference genome, GRCm39, using Hisat2 v2.2.1 software. Reads were then preprocessed with SAMtools v1.13 to transform Sequence Alignment/Map files into Binary Alignment/Map files and sorted. The number of reads covered by each gene is calculated by HTSeq-Count v1.99.2. Downstream data analysis was performed with R v4.4.1. Analysis of differentially expressed genes was performed using DESeq2 v1.44.0. Genes with <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 and |log<sub>2</sub>fold change| &#x0003e;log<sub>2</sub>(1.5) were determined to show statistically significant differences in group comparison. Over-representation analysis and gene set enrichment analysis were performed using clusterProfiler v4.12.0 package in GO, KEGG, WikiPathways, Reactome and the Hallmarks of the Molecular signatures database. Principal component analysis (PCA) plots and volcano plot were visualized using ggplot2 v3.5.1. Heat maps were visualized using heatmap v1.0.12.</p></sec><sec id="Sec29"><title>Analysis of cytokine secretion by T<sub>reg</sub> subsets using Multiplex</title><p id="Par58">rT<sub>reg</sub>, aT<sub>reg</sub> or kT<sub>reg</sub> cells were isolated from IL-33-treated young mice by FACS. A total of 5.5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells were incubated in 200&#x02009;&#x000b5;l of complete RPMI medium supplemented with 10% FBS in resting conditions or in presence of Mouse T-Activator Dynabeads for 24&#x02009;h. The cells were centrifuged at 300<italic>g</italic> for 5&#x02009;min, and the supernatant was used for cytokine detection with magnetic bead technology (Invitrogen, Cytokine &#x00026; Chemokine 26-Plex Mouse ProcartaPlex Panel 1).</p></sec><sec id="Sec30"><title>Electron microscopy</title><p id="Par59">For electron microscopy, splenocytes from old mice were labeled for 30&#x02009;min with 50&#x02009;nM MitoTracker Green FM and 200&#x02009;nM Mitotracker DeepRed FM before extracellular staining. Cells were then labeled with a fluorochrome-conjugated antibody against CD4, and MtG<sup>hi</sup>MtDR<sup>hi</sup> and MtG<sup>lo</sup>MtDR<sup>lo</sup> alive CD4<sup>+</sup> T cells were isolated by FACS. After sorting, cells were fixed with 4% paraformaldehyde, 2% glutaraldehyde diluted in 0.1&#x02009;M phosphate buffer. Cells were postfixed with 1% osmiun tetroxide and 1% potassium ferrocyanide for 60&#x02009;min. After washing, incubation with 0.15% tannic acid in buffer phosphate 0.1&#x02009;M for 1&#x02009;min was achieved. After washing, cells were counterstained with uranyl acetate 2% for 1&#x02009;h. Then, cells were dehydrated with lowering concentrations of ethanol and embedded in resin EPON. The preparations were examined with a transmission electron microscope (JEM1400 Flash, Jeol), and images were acquired with a CMOS Oneview camera (Gatan).</p></sec><sec id="Sec31"><title>Reanalysis of scRNA-seq data</title><p id="Par60">scRNA-seq data were extracted from a previously published work<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> and reanalyzed with the Seurat package v4.2.0 in R v4.1.3. Variable genes were identified with the FindVariablesFeatures function across the range of expression values and used to perform a PCA with the RunPCA function. Clustering was performed with the FindClusters function with the Leiden algorithm and the first 20 principal components. Cluster identification was done with the FindMarkers function in each subset with a minimum log fold change of 0.25 and a <italic>P</italic> value &#x0003c;10<sup>-3</sup>. The kT<sub>reg</sub> cluster was separated by using the FindSubCluster function in the aT<sub>reg</sub> cluster and then identified with the FindMarkers function.</p></sec><sec id="Sec32"><title>Statistics and reproducibility analysis</title><p id="Par61">Unless otherwise specified, <italic>n</italic> represents the number of individual biological replicates and is represented in graphs as one dot per sample. All the data are extracted from one representative experiment (<italic>n</italic>&#x02009;&#x02265;&#x02009;3 per group) of a minimum of two separate experiments. Flow cytometry plots are representative of at least three replicates. No statistical method was used to predetermine sample size, but a minimum of three samples were used per experimental group and condition. Data collection and analysis were not performed blind to the age of the mice.</p><p id="Par62">For statistical analysis, GraphPad Prism (version 9) was used. Data are expressed as mean&#x02009;&#x000b1;&#x02009;s.e.m., unless otherwise indicated. Outliers were identified by the ROUT method (5%) and removed. Comparisons for two groups were calculated using unpaired two-tailed Student&#x02019;s <italic>t</italic>-tests (for two groups meeting the normal distribution criteria) or Mann&#x02013;Whitney <italic>U</italic> test (for two groups without normal distribution) according to the Shapiro&#x02013;Wilk normality test. When comparing different populations within the same mouse, comparisons were calculated using two-tailed paired Student&#x02019;s <italic>t</italic>-tests (for two groups meeting the normal distribution criteria) or Wilcoxon test (for two groups without normal distribution) according to the Shapiro&#x02013;Wilk normality test. Comparisons for more than two groups were calculated using one-way analysis of variance (ANOVA) with Tukey&#x02019;s correction for multiple comparisons (for three or more groups meeting the normal distribution criteria) or Kruskal&#x02013;Wallis test with Dunn&#x02019;s correction for multiple comparisons (for three or more groups without normal distribution) according to the Shapiro&#x02013;Wilk normality test. When comparing at least three distinct populations within the same mouse, comparisons were calculated using repeated measures (RM) one-way ANOVA with Tukey&#x02019;s correction for multiple comparisons (for samples meeting the normal distribution criteria) or Friedman test with Dunn&#x02019;s correction for multiple comparisons (for at least three groups without normal distribution) according to the Shapiro&#x02013;Wilk normality test.</p><p id="Par63">The statistical significance is represented as follows: *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05, **0.05&#x02009;&#x0003c;&#x02009;<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***0.01&#x02009;&#x0003c;&#x02009;<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001.</p></sec><sec id="Sec33"><title>Reporting summary</title><p id="Par64">Further information on research design is available in the <xref rid="MOESM1" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec35" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="43587_2025_855_MOESM1_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="43587_2025_855_MOESM2_ESM.xlsx"><label>Supplementary Table 1</label><caption><p>Differentially expressed genes in the kT<sub>reg</sub> cluster.</p></caption></media></supplementary-material>
</p></sec><sec id="Sec36" sec-type="supplementary-material"><title>Source data</title><p>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="43587_2025_855_MOESM3_ESM.xlsx"><label>Source Data Fig. 1</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="43587_2025_855_MOESM4_ESM.xlsx"><label>Source Data Fig. 2</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="43587_2025_855_MOESM5_ESM.xlsx"><label>Source Data Fig. 3</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="43587_2025_855_MOESM6_ESM.xlsx"><label>Source Data Fig. 4</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="43587_2025_855_MOESM7_ESM.xlsx"><label>Source Data Fig. 5</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="43587_2025_855_MOESM8_ESM.xlsx"><label>Source Data Fig. 6</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="43587_2025_855_MOESM9_ESM.xlsx"><label>Source Data Fig. 7</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="43587_2025_855_MOESM10_ESM.xlsx"><label>Source Data Fig. 8</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM11"><media xlink:href="43587_2025_855_MOESM11_ESM.xlsx"><label>Source Data Extended Data Fig. 1</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM12"><media xlink:href="43587_2025_855_MOESM12_ESM.xlsx"><label>Source Data Extended Data Fig. 2</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM13"><media xlink:href="43587_2025_855_MOESM13_ESM.xlsx"><label>Source Data Extended Data Fig. 3</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM14"><media xlink:href="43587_2025_855_MOESM14_ESM.xlsx"><label>Source Data Extended Data Fig. 4</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM15"><media xlink:href="43587_2025_855_MOESM15_ESM.xlsx"><label>Source Data Extended Data Fig. 5</label><caption><p>Statistical source data.</p></caption></media></supplementary-material>
</p></sec></body><back><app-group><app id="App1"><sec id="Sec34"><title>Extended data</title><p id="Par69">
<fig id="Fig9"><label>Extended Data Fig. 1</label><caption><title>CD4<sup>+</sup> T cells progressively lose mitochondrial mass and mitochondrial membrane potential during aging.</title><p>(<bold>a</bold>) Representative plots of mitochondrial mass and mitochondrial membrane potential analyzed by flow cytometry in CD4<sup>+</sup> T cells treated or not treated with oligomycin. Cells were gated as MtG<sup>hi</sup>MtDR<sup>hi</sup>, MtG<sup>hi</sup>MtDR<sup>lo</sup> and MtG<sup>lo</sup>MtDR<sup>lo</sup>. Mitochondrial mass analyzed as gMFI of MtG (<bold>b</bold>) and mitochondrial membrane potential analyzed as gMFI of MtDR (<bold>c</bold>) measured by flow cytometry in circulating CD4<sup>+</sup> T cells from mouse from 2- (n&#x02009;=&#x02009;5), 9- (n&#x02009;=&#x02009;5), 13- (n&#x02009;=&#x02009;5), 17- (n&#x02009;=&#x02009;5) and 21- (n&#x02009;=&#x02009;6) month-old mice. (<bold>d</bold>) Representative flow cytometry plots and quantifications of the simultaneous analysis of MtG and TMRM in splenic CD4<sup>+</sup> T cells from young (2-month-old, n&#x02009;=&#x02009;5) and old (21-month-old, n&#x02009;=&#x02009;4) mice. (<bold>e</bold>) Quantification of the MtDR/MtG ratio in MtG<sup>hi</sup>MtDR<sup>hi</sup> and MtG<sup>lo</sup>MtDR<sup>lo</sup> CD4<sup>+</sup> T cells from mice at different ages (n&#x02009;=&#x02009;6 mice per group). gMFI: Geometric Mean Fluorescence Intensity; MtG: Mitotracker Green; MtDR: Mitotracker DeepRed. Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using one-way ANOVA with post hoc Tukey&#x02019;s correction (<bold>b</bold>), Kruskal-Wallis test with post hoc Dunn&#x02019;s correction (<bold>c</bold>), two-tailed Student&#x02019;s t test [(<bold>d</bold>): TMRM<sup>hi</sup>MtG<sup>hi</sup>; (<bold>e</bold>)] or two-tailed unpaired Welch&#x02019;s t test [(<bold>d</bold>): TMRM<sup>lo</sup>MtG<sup>lo</sup>] (<bold>b</bold>). *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p>
<xref rid="MOESM11" ref-type="media">Source data</xref>
</p></caption><graphic position="anchor" xlink:href="43587_2025_855_Fig9_ESM" id="d33e3997"/></fig>
</p><p id="Par70">
<fig id="Fig10"><label>Extended Data Fig. 2</label><caption><title>Identification of age-associated T cells by scRNAseq and by spectral flow cytometry.</title><p>(<bold>a</bold>) UMAP representation of CD4<sup>+</sup> T cells from young (left) and old mice (right) analyzed by scRNAseq (top) or spectral flow cytometry (bottom). (<bold>b</bold>) UMAP with clustering overlay showing the distribution of the different clusters of CD4<sup>+</sup> T cells identified by scRNAseq or by spectral flow cytometry: naive (blue), na&#x000ef;ve_ISG15 (dark blue), rTregs (yellow), aTregs (orange), kTregs (red), TEM (light green), cytotoxic (brown) and exhausted (dark green) (n&#x02009;=&#x02009;4 mice per group). (<bold>c</bold>) Percentage of circulating KLRG1<sup>+</sup> cells in CD4<sup>+</sup> T cells from 2- (n&#x02009;=&#x02009;6), 9- (n&#x02009;=&#x02009;6), 13- (n&#x02009;=&#x02009;5), 17- (n&#x02009;=&#x02009;6) and 21- (n&#x02009;=&#x02009;6) month-old mice assessed by flow cytometry. (<bold>d-e</bold>) Percentage of splenic KLRG1<sup>+</sup> cells in CD4<sup>+</sup>FOXP3<sup>+</sup>CD25<sup>+</sup> T cells (<bold>d</bold>) or in CD4<sup>+</sup> T cells (<bold>e</bold>) from 2- (n&#x02009;=&#x02009;3), 9- (n&#x02009;=&#x02009;4), 17- (n&#x02009;=&#x02009;4) and 21- (n&#x02009;=&#x02009;4) month-old mice. Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using one-way ANOVA with post hoc Tukey&#x02019;s correction [(<bold>c</bold>), (<bold>d</bold>), (<bold>e</bold>)]. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p>
<xref rid="MOESM12" ref-type="media">Source data</xref>
</p></caption><graphic position="anchor" xlink:href="43587_2025_855_Fig10_ESM" id="d33e4077"/></fig>
</p><p id="Par71">
<fig id="Fig11"><label>Extended Data Fig. 3</label><caption><title>Reanalysis of publicly available scRNAseq data identifies kTregs with a pro-inflammatory signature.</title><p>(<bold>a</bold>) UMAP representation and clustering of a new analysis of publicly available scRNAseq data from CD4<sup>+</sup> T cells from young and old mice. Clusters are colored as na&#x000ef;ve (blue), rTregs (yellow), aTregs (orange), kTregs (red), T<sub>EM</sub> (light green), cytotoxic (brown) and exhausted (dark green). (<bold>b</bold>) Quantification of the percentage of kTreg cells in young and old mice (n&#x02009;=&#x02009;4 mice per group). (<bold>c</bold>) Comparative expression of genes related to Treg function in aTreg and kTreg (n&#x02009;=&#x02009;4 mice per group). (<bold>d</bold>) Violin plots showing the expression of several pro-inflammatory markers in each cluster of CD4<sup>+</sup> T cells (n&#x02009;=&#x02009;4 mice per group). Each dot represents an individual mouse. Box-and-whisker plots show the median, the maximum, the minimum and 25th and 75th percentiles. Statistical analysis was performed using two-tailed unpaired Welch&#x02019;s t test (<bold>b</bold>). Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p>
<xref rid="MOESM13" ref-type="media">Source data</xref>
</p></caption><graphic position="anchor" xlink:href="43587_2025_855_Fig11_ESM" id="d33e4119"/></fig>
</p><p id="Par72">
<fig id="Fig12"><label>Extended Data Fig. 4</label><caption><title>Analysis of the expression of different transcription factors in the Treg subsets.</title><p>Representative histograms and quantifications of the expression of different transcription factors by flow cytometry in splenic rTreg (yellow), aTreg (orange) and kTregs (red) from young (2-month-old) mice (n&#x02009;=&#x02009;6 mice per group) measured as gMFI. gMFI values are relative to the MFI in rTregs (n&#x02009;=&#x02009;6 per group). gMFI: Geometric Mean Fluorescence Intensity. Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using Friedman test with post hoc Dunn&#x02019;s correction. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p>
<xref rid="MOESM14" ref-type="media">Source data</xref>
</p></caption><graphic position="anchor" xlink:href="43587_2025_855_Fig12_ESM" id="d33e4151"/></fig>
</p><p id="Par73">
<fig id="Fig13"><label>Extended Data Fig. 5</label><caption><title>KLRG1<sup>+</sup> Tregs show a pro-inflammatory phenotype and induce inflammation.</title><p>(<bold>a-b</bold>) <italic>In vitro</italic> assessment of the suppressive activity of KLRG1<sup>+</sup> Tregs. KLRG1<sup>-</sup> or KLRG1<sup>+</sup> Tregs were sorted from old (22-month-old) and co-cultured with CD45.1 na&#x000ef;ve CD4<sup>+</sup> T responder cells labelled with CellTrace Violet at 2:1 ratio (2 na&#x000ef;ve:1 Treg) for 72&#x02009;h in the presence of &#x003b1;-CD3/&#x003b1;-CD28 (n&#x02009;=&#x02009;3 mice). (<bold>a</bold>) Representative histogram of the CellTrace Violet signal measured by flow cytometry in CD45.1 CD4<sup>+</sup> T conventional responder cells after 72&#x02009;h of culture. (<bold>b</bold>) Quantification of the capacity of KLRG1<sup>-</sup> and KLRG1<sup>+</sup> Treg cells to suppress the proliferation of CD45.1 CD4<sup>+</sup> responder T cells. The percentage of suppression was determined as: 100 &#x02212; (% of proliferating cells with Tregs)/(% of proliferating cells without Tregs). (<bold>c</bold>) Representative histograms and quantifications of the expression of different cytokines by flow cytometry in splenic rTreg (yellow), aTreg (orange) and kTregs (red) from old (21-month-old) mice measured as gMFI. gMFI values are relative to the MFI in rTregs (n&#x02009;=&#x02009;6 mice per group). (<bold>d</bold>-<bold>e</bold>) Analysis of the secretion of different cytokines by the Treg subsets in activating conditions using multiplex. Treg subsets were sorted from young mice injected with IL-2&#x02009;+&#x02009;IL-33 and incubated during 24&#x02009;h in the presence of &#x003b1;-CD3/&#x003b1;-CD28 before the assay (n&#x02009;=&#x02009;3 mice). (<bold>d</bold>) Heatmap and statistical comparisons of the secretion of different cytokines by rTreg, aTreg and kTregs. Heatmap values are relative to the maximum of each cytokine. (<bold>e</bold>) Quantification of IL-10, IL-6, GM-CSF and CXCL2 secreted by activated rTreg, aTreg and kTregs. (<bold>f-h</bold>) <italic>In vivo</italic> assessment of the pro-inflammatory activity of KLRG1<sup>+</sup> Tregs: CD3&#x003b5;<sup>-/-</sup> T cell deficient mice were injected with splenic KLRG1<sup>-</sup> or KLRG1<sup>+</sup> Tregs isolated from young mice injected with IL-2&#x02009;+&#x02009;IL-33. The mice were analyzed four months after the adoptive transfer (n&#x02009;=&#x02009;3 mice per group). (<bold>f</bold>) Schematic diagram depicting the adoptive transfer of kTregs. (<bold>g</bold>) Spleen weight from CD3&#x003b5;<sup>-/-</sup> mice non-injected or injected with KLRG1<sup>-</sup> or KLRG1<sup>+</sup> T cells. (<bold>h</bold>) Quantification of the percentage of circulating neutrophils or basophils in CD3&#x003b5;<sup>-/-</sup> mice non-injected or injected with KLRG1<sup>-</sup> or KLRG1<sup>+</sup> T cells. gMFI: Geometric Mean Fluorescence Intensity. Each dot represents an individual mouse. Data are presented as mean values&#x02009;&#x000b1;&#x02009;SEM. Statistical analysis was performed using two-tailed unpaired Student&#x02019;s t test (<bold>b</bold>), Friedman test with post hoc Dunn&#x02019;s correction [(<bold>c</bold>), (<bold>e</bold>): IL-6], RM one-way ANOVA with post hoc Tukey&#x02019;s correction [(<bold>d</bold>); (<bold>e</bold>): IL10, GM-CSF, CXCL2] or ANOVA with post hoc Tukey&#x02019;s correction [(<bold>g</bold>), (<bold>h</bold>)]. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001; ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001. Exact <italic>P</italic> values and additional statistical parameters can be found in the source data.</p><p>
<xref rid="MOESM15" ref-type="media">Source data</xref>
</p></caption><graphic position="anchor" xlink:href="43587_2025_855_Fig13_ESM" id="d33e4292"/></fig>
</p><p id="Par74">
<fig id="Fig14"><label>Extended Data Fig. 6</label><caption><title>Gating strategy to identify KLRG1<sup>+</sup> Tregs in human PBMCs.</title><p>Gating strategy followed to identify KLRG1<sup>+</sup> Tregs (CD45<sup>+</sup>CD3<sup>+</sup>CD4<sup>+</sup>CD8<sup>-</sup>CD25<sup>+</sup>IL7R<sup>-</sup>KLRG1<sup>+</sup>) in human PBMCs.</p></caption><graphic position="anchor" xlink:href="43587_2025_855_Fig14_ESM" id="d33e4324"/></fig>
</p></sec></app></app-group><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><sec id="FPar1"><title>Extended data</title><p id="Par65">is available for this paper at 10.1038/s43587-025-00855-9.</p></sec><sec id="FPar2" sec-type="supplementary-material"><title>Supplementary information</title><p id="Par66">The online version contains supplementary material available at 10.1038/s43587-025-00855-9.</p></sec></sec><ack><title>Acknowledgements</title><p>Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. This study was supported by European Research Council grant ERC-2021-CoG 101044248-LetTBe, and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid, Ministerio de Ciencia e Innovacion, Spain (grants PID2022-141169OB-I00 and PID2022-138295OB-I00). GENYAL Clinical Trials Platform of IMDEA Alimentaci&#x000f3;n led by A. Ram&#x000ed;rez de Molina and R. Ramos Ruiz conducted the volunteer recruitment and human clinical trial. Flow cytometry of human samples was conducted by Flow Cytometry Unit, CNIC, being the cytometer part of the grant EQC2018-005009-P funded by MCIN/AEI/10.13039/501100011033 and by &#x02018;ERDF A way of making Europe&#x02019;. G.S.-H. is supported by a FPI-UAM grant (Universidad Aut&#x000f3;noma de Madrid). E.G.-R. was funded by a Juan de la Cierva grant (IJC2018-036850-I; Universidad Aut&#x000f3;noma de Madrid). M.G. and J.I.E.-L. are supported by FPU grants (FPU19/02576 and FPU20/04066, respectively), both from Ministerio de Ciencia, Innovaci&#x000f3;n y Universidades (Spain). E.C. is supported by SI4/PJI/2024-00166 from Comunidad de Madrid and UAM (Spain). S.D.-P. was funded by a PIPF grant (PIPF-2022/SAL-GL-25208), from Comunidad de Madrid (Spain). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>G.S.-H., E.G.-R., E.C. and M.M. set up the research project and designed the experiments. G.S.-H., E.G.-R., E.C., J.I.E.-L., M.M.G., S.D.P., I.F.Q. and E.M.B. conducted most of the experiments and acquired the data. M.J.R. performed and analyzed the data in Fig. <xref rid="Fig1" ref-type="fig">1f,g</xref>. V.Z. provided technical and scientific support. C.M.F.-D. and M.B.A.-F. performed the experiments and analyzed the data in Fig. <xref rid="Fig8" ref-type="fig">8</xref> under the supervision of A.R. A.F.A., D.A., S.J., A.d.S., F.S.-C. and C.T. performed bioinformatic analysis. G.S.-H. assembled the figures. G.S.-H. and M.M. wrote the manuscript. M.M. obtained financial support and provided supervision.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar3"><title>Peer review information</title><p id="Par67"><italic>Nature Aging</italic> thanks Jorg Goronzy and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.</p></sec></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data supporting the findings of this study are available within the Article and its <xref ref-type="sec" rid="Sec35">Supplementary Information</xref>. The scRNA-seq dataset reanalyzed is publicly available (Single Cell Portal; accession number SCP490)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. The RNA-seq dataset generated during the current study is available in the Gene Expression Omnibus repository (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279926">GSE279926</ext-link>). The rest of the data were originally generated.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par68">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Franceschi</surname><given-names>C</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><article-title>Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases</article-title><source>J. Gerontol. A</source><year>2014</year><volume>69</volume><fpage>S4</fpage><lpage>S9</lpage><pub-id pub-id-type="doi">10.1093/gerona/glu057</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Franceschi, C. &#x00026; Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. <italic>J. Gerontol. A</italic><bold>69</bold>, S4&#x02013;S9 (2014).</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Fabbri</surname><given-names>E</given-names></name></person-group><article-title>Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty</article-title><source>Nat. Rev. Cardiol.</source><year>2018</year><volume>15</volume><fpage>505</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1038/s41569-018-0064-2</pub-id><pub-id pub-id-type="pmid">30065258</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Ferrucci, L. &#x00026; Fabbri, E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. <italic>Nat. Rev. Cardiol.</italic><bold>15</bold>, 505&#x02013;522 (2018).<pub-id pub-id-type="pmid">30065258</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Goronzy</surname><given-names>JJ</given-names></name><name><surname>Weyand</surname><given-names>CM</given-names></name></person-group><article-title>Immune aging and autoimmunity</article-title><source>Cell. Mol. Life Sci.</source><year>2012</year><volume>69</volume><fpage>1615</fpage><lpage>1623</lpage><pub-id pub-id-type="doi">10.1007/s00018-012-0970-0</pub-id><pub-id pub-id-type="pmid">22466672</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Goronzy, J. J. &#x00026; Weyand, C. M. Immune aging and autoimmunity. <italic>Cell. Mol. Life Sci.</italic><bold>69</bold>, 1615&#x02013;1623 (2012).<pub-id pub-id-type="pmid">22466672</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Carrasco</surname><given-names>E</given-names></name><etal/></person-group><article-title>The role of T cells in age-related diseases</article-title><source>Nat. Rev. Immunol.</source><year>2022</year><volume>22</volume><fpage>97</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1038/s41577-021-00557-4</pub-id><pub-id pub-id-type="pmid">34099898</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Carrasco, E. et al. The role of T cells in age-related diseases. <italic>Nat. Rev. Immunol.</italic><bold>22</bold>, 97&#x02013;111 (2022).<pub-id pub-id-type="pmid">34099898</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Elyahu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes</article-title><source>Sci. Adv.</source><year>2019</year><volume>5</volume><fpage>eaaw8330</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aaw8330</pub-id><pub-id pub-id-type="pmid">31457092</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Elyahu, Y. et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. <italic>Sci. Adv.</italic><bold>5</bold>, eaaw8330 (2019).<pub-id pub-id-type="pmid">31457092</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Ono</surname><given-names>M</given-names></name></person-group><article-title>Regulatory T cells and immune tolerance</article-title><source>Cell</source><year>2008</year><volume>133</volume><fpage>775</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.05.009</pub-id><pub-id pub-id-type="pmid">18510923</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Sakaguchi, S., Yamaguchi, T., Nomura, T. &#x00026; Ono, M. Regulatory T cells and immune tolerance. <italic>Cell</italic><bold>133</bold>, 775&#x02013;787 (2008).<pub-id pub-id-type="pmid">18510923</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Dominguez</surname><given-names>AL</given-names></name><name><surname>Lustgarten</surname><given-names>J</given-names></name></person-group><article-title>High accumulation of T regulatory cells prevents the activation of immune responses in aged animals</article-title><source>J. Immunol.</source><year>2006</year><volume>177</volume><fpage>8348</fpage><lpage>8355</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.12.8348</pub-id><pub-id pub-id-type="pmid">17142731</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Sharma, S., Dominguez, A. L. &#x00026; Lustgarten, J. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. <italic>J. Immunol.</italic><bold>177</bold>, 8348&#x02013;8355 (2006).<pub-id pub-id-type="pmid">17142731</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Trujillo-Vargas</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Immune phenotype of the CD4<sup>+</sup> T cells in the aged lymphoid organs and lacrimal glands</article-title><source>GeroScience</source><year>2022</year><volume>44</volume><fpage>2105</fpage><lpage>2128</lpage><pub-id pub-id-type="doi">10.1007/s11357-022-00529-z</pub-id><pub-id pub-id-type="pmid">35279788</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Trujillo-Vargas, C. M. et al. Immune phenotype of the CD4<sup>+</sup> T cells in the aged lymphoid organs and lacrimal glands. <italic>GeroScience</italic><bold>44</bold>, 2105&#x02013;2128 (2022).<pub-id pub-id-type="pmid">35279788</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Soto-Heredero</surname><given-names>G</given-names></name><name><surname>G&#x000f3;mez de las Heras</surname><given-names>MM</given-names></name><name><surname>Escrig-Larena</surname><given-names>JI</given-names></name><name><surname>Mittelbrunn</surname><given-names>M</given-names></name></person-group><article-title>Extremely differentiated T cell subsets contribute to tissue deterioration during aging</article-title><source>Annu. Rev. Immunol.</source><year>2023</year><volume>41</volume><fpage>181</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-101721-064501</pub-id><pub-id pub-id-type="pmid">37126417</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Soto-Heredero, G., G&#x000f3;mez de las Heras, M. M., Escrig-Larena, J. I. &#x00026; Mittelbrunn, M. Extremely differentiated T cell subsets contribute to tissue deterioration during aging. <italic>Annu. Rev. Immunol.</italic><bold>41</bold>, 181&#x02013;205 (2023).<pub-id pub-id-type="pmid">37126417</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo</surname><given-names>EC</given-names></name><etal/></person-group><article-title>Senescence-induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics</article-title><source>Aging Cell</source><year>2022</year><volume>21</volume><fpage>e13525</fpage><pub-id pub-id-type="doi">10.1111/acel.13525</pub-id><pub-id pub-id-type="pmid">34962049</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Lorenzo, E. C. et al. Senescence-induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics. <italic>Aging Cell</italic><bold>21</bold>, e13525 (2022).<pub-id pub-id-type="pmid">34962049</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Kuswanto</surname><given-names>W</given-names></name><etal/></person-group><article-title>Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells</article-title><source>Immunity</source><year>2016</year><volume>44</volume><fpage>355</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.01.009</pub-id><pub-id pub-id-type="pmid">26872699</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Kuswanto, W. et al. Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells. <italic>Immunity</italic><bold>44</bold>, 355&#x02013;367 (2016).<pub-id pub-id-type="pmid">26872699</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Tsaknaridis</surname><given-names>L</given-names></name><etal/></person-group><article-title>Functional assay for human CD4<sup>+</sup>CD25<sup>+</sup> Treg cells reveals an age-dependent loss of suppressive activity</article-title><source>J. Neurosci. Res.</source><year>2003</year><volume>74</volume><fpage>296</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1002/jnr.10766</pub-id><pub-id pub-id-type="pmid">14515359</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Tsaknaridis, L. et al. Functional assay for human CD4<sup>+</sup>CD25<sup>+</sup> Treg cells reveals an age-dependent loss of suppressive activity. <italic>J. Neurosci. Res.</italic><bold>74</bold>, 296&#x02013;308 (2003).<pub-id pub-id-type="pmid">14515359</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Raynor</surname><given-names>J</given-names></name><etal/></person-group><article-title>IL-15 fosters age-driven regulatory T cell accrual in the face of declining IL-2 levels</article-title><source>Front. Immunol.</source><year>2013</year><volume>4</volume><fpage>161</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2013.00161</pub-id><pub-id pub-id-type="pmid">23805138</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Raynor, J. et al. IL-15 fosters age-driven regulatory T cell accrual in the face of declining IL-2 levels. <italic>Front. Immunol.</italic><bold>4</bold>, 161 (2013).<pub-id pub-id-type="pmid">23805138</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Lages</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation</article-title><source>J. Immunol.</source><year>2008</year><volume>181</volume><fpage>1835</fpage><lpage>1848</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.3.1835</pub-id><pub-id pub-id-type="pmid">18641321</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Lages, C. S. et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. <italic>J. Immunol.</italic><bold>181</bold>, 1835&#x02013;1848 (2008).<pub-id pub-id-type="pmid">18641321</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Raynor</surname><given-names>J</given-names></name><etal/></person-group><article-title>IL-6 and ICOS antagonize Bim and promote regulatory T cell accrual with age</article-title><source>J. Immunol.</source><year>2015</year><volume>195</volume><fpage>944</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1500443</pub-id><pub-id pub-id-type="pmid">26109645</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Raynor, J. et al. IL-6 and ICOS antagonize Bim and promote regulatory T cell accrual with age. <italic>J. Immunol.</italic><bold>195</bold>, 944&#x02013;952 (2015).<pub-id pub-id-type="pmid">26109645</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Morales-Nebreda</surname><given-names>L</given-names></name><etal/></person-group><article-title>Aging imparts cell-autonomous dysfunction to regulatory T cells during recovery from influenza pneumonia</article-title><source>JCI Insight</source><year>2021</year><volume>6</volume><fpage>e141690</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.141690</pub-id><pub-id pub-id-type="pmid">33600379</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Morales-Nebreda, L. et al. Aging imparts cell-autonomous dysfunction to regulatory T cells during recovery from influenza pneumonia. <italic>JCI Insight</italic><bold>6</bold>, e141690 (2021).<pub-id pub-id-type="pmid">33600379</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Overacre-Delgoffe</surname><given-names>AE</given-names></name><etal/></person-group><article-title>Interferon-&#x003b3; drives Treg fragility to promote anti-tumor immunity</article-title><source>Cell</source><year>2017</year><volume>169</volume><fpage>1130</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.005</pub-id><pub-id pub-id-type="pmid">28552348</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Overacre-Delgoffe, A. E. et al. Interferon-&#x003b3; drives Treg fragility to promote anti-tumor immunity. <italic>Cell</italic><bold>169</bold>, 1130&#x02013;1141 (2017).<pub-id pub-id-type="pmid">28552348</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Zagorulya</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer</article-title><source>Immunity</source><year>2023</year><volume>56</volume><fpage>386</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2023.01.010</pub-id><pub-id pub-id-type="pmid">36736322</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Zagorulya, M. et al. Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer. <italic>Immunity</italic><bold>56</bold>, 386&#x02013;405 (2023).<pub-id pub-id-type="pmid">36736322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Henson</surname><given-names>SM</given-names></name><etal/></person-group><article-title>KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8<sup>+</sup> T cells</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>6619</fpage><lpage>6628</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-01-199588</pub-id><pub-id pub-id-type="pmid">19406987</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Henson, S. M. et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8<sup>+</sup> T cells. <italic>Blood</italic><bold>113</bold>, 6619&#x02013;6628 (2009).<pub-id pub-id-type="pmid">19406987</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>NS</given-names></name><etal/></person-group><article-title>Inflammation directs memory precursor and short-lived effector CD8<sup>+</sup> T cell fates via the graded expression of T-bet transcription factor</article-title><source>Immunity</source><year>2007</year><volume>27</volume><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.07.010</pub-id><pub-id pub-id-type="pmid">17723218</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8<sup>+</sup> T cell fates via the graded expression of T-bet transcription factor. <italic>Immunity</italic><bold>27</bold>, 281&#x02013;295 (2007).<pub-id pub-id-type="pmid">17723218</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Henson</surname><given-names>SM</given-names></name><name><surname>Akbar</surname><given-names>AN</given-names></name></person-group><article-title>KLRG1&#x02013;more than a marker for T cell senescence</article-title><source>Age</source><year>2009</year><volume>31</volume><fpage>285</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1007/s11357-009-9100-9</pub-id><pub-id pub-id-type="pmid">19479342</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Henson, S. M. &#x00026; Akbar, A. N. KLRG1&#x02013;more than a marker for T cell senescence. <italic>Age</italic><bold>31</bold>, 285&#x02013;291 (2009).<pub-id pub-id-type="pmid">19479342</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Voehringer</surname><given-names>D</given-names></name><etal/></person-group><article-title>Viral infections induce abundant numbers of senescent CD8 T cells</article-title><source>J. Immunol.</source><year>2001</year><volume>167</volume><fpage>4838</fpage><lpage>4843</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.167.9.4838</pub-id><pub-id pub-id-type="pmid">11673487</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Voehringer, D. et al. Viral infections induce abundant numbers of senescent CD8 T cells. <italic>J. Immunol.</italic><bold>167</bold>, 4838&#x02013;4843 (2001).<pub-id pub-id-type="pmid">11673487</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartzkopff</surname><given-names>S</given-names></name><etal/></person-group><article-title>Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans</article-title><source>J. Immunol.</source><year>2007</year><volume>179</volume><fpage>1022</fpage><lpage>1029</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.2.1022</pub-id><pub-id pub-id-type="pmid">17617594</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Schwartzkopff, S. et al. Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans. <italic>J. Immunol.</italic><bold>179</bold>, 1022&#x02013;1029 (2007).<pub-id pub-id-type="pmid">17617594</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wan</surname><given-names>S</given-names></name><name><surname>Tao</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>E</given-names></name></person-group><article-title>KLRG1 restricts memory T cell antitumor immunity</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>61670</fpage><lpage>61678</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.11430</pub-id><pub-id pub-id-type="pmid">27557510</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Li, L., Wan, S., Tao, K., Wang, G. &#x00026; Zhao, E. KLRG1 restricts memory T cell antitumor immunity. <italic>Oncotarget</italic><bold>7</bold>, 61670&#x02013;61678 (2016).<pub-id pub-id-type="pmid">27557510</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Ramello</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Polyfunctional KLRG-1<sup>+</sup>CD57<sup>+</sup> senescent CD4<sup>+</sup> T cells infiltrate tumors and are expanded in peripheral blood from breast cancer patients</article-title><source>Front. Immunol.</source><year>2021</year><volume>12</volume><fpage>713132</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2021.713132</pub-id><pub-id pub-id-type="pmid">34386013</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Ramello, M. C. et al. Polyfunctional KLRG-1<sup>+</sup>CD57<sup>+</sup> senescent CD4<sup>+</sup> T cells infiltrate tumors and are expanded in peripheral blood from breast cancer patients. <italic>Front. Immunol.</italic><bold>12</bold>, 713132 (2021).<pub-id pub-id-type="pmid">34386013</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>G</given-names></name><etal/></person-group><article-title>IL-2 receptor signaling is essential for the development of Klrg1<sup>+</sup> terminally differentiated T regulatory cells</article-title><source>J. Immunol.</source><year>2012</year><volume>189</volume><fpage>1780</fpage><lpage>1791</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1103768</pub-id><pub-id pub-id-type="pmid">22786769</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Cheng, G. et al. IL-2 receptor signaling is essential for the development of Klrg1<sup>+</sup> terminally differentiated T regulatory cells. <italic>J. Immunol.</italic><bold>189</bold>, 1780&#x02013;1791 (2012).<pub-id pub-id-type="pmid">22786769</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Ot&#x000ed;n</surname><given-names>C</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>The hallmarks of aging</article-title><source>Cell</source><year>2013</year><volume>153</volume><fpage>1194</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.039</pub-id><pub-id pub-id-type="pmid">23746838</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">L&#x000f3;pez-Ot&#x000ed;n, C., Blasco, M. A., Partridge, L., Serrano, M. &#x00026; Kroemer, G. The hallmarks of aging. <italic>Cell</italic><bold>153</bold>, 1194&#x02013;1217 (2013).<pub-id pub-id-type="pmid">23746838</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Ron-Harel</surname><given-names>N</given-names></name><etal/></person-group><article-title>Defective respiration and one-carbon metabolism contribute to impaired na&#x000ef;ve T cell activation in aged mice</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>13347</fpage><lpage>13352</lpage><pub-id pub-id-type="doi">10.1073/pnas.1804149115</pub-id><pub-id pub-id-type="pmid">30530686</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Ron-Harel, N. et al. Defective respiration and one-carbon metabolism contribute to impaired na&#x000ef;ve T cell activation in aged mice. <italic>Proc. Natl Acad. Sci. USA</italic><bold>115</bold>, 13347&#x02013;13352 (2018).<pub-id pub-id-type="pmid">30530686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Bektas</surname><given-names>A</given-names></name><etal/></person-group><article-title>Age-associated changes in human CD4<sup>+</sup> T cells point to mitochondrial dysfunction consequent to impaired autophagy</article-title><source>Aging</source><year>2019</year><volume>11</volume><fpage>9234</fpage><lpage>9263</lpage><pub-id pub-id-type="doi">10.18632/aging.102438</pub-id><pub-id pub-id-type="pmid">31707363</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Bektas, A. et al. Age-associated changes in human CD4<sup>+</sup> T cells point to mitochondrial dysfunction consequent to impaired autophagy. <italic>Aging</italic><bold>11</bold>, 9234&#x02013;9263 (2019).<pub-id pub-id-type="pmid">31707363</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Steinert</surname><given-names>EM</given-names></name><name><surname>Vasan</surname><given-names>K</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name></person-group><article-title>Mitochondrial metabolism regulation of T cell-mediated immunity</article-title><source>Annu. Rev. Immunol.</source><year>2021</year><volume>39</volume><fpage>395</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-101819-082015</pub-id><pub-id pub-id-type="pmid">33902315</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Steinert, E. M., Vasan, K. &#x00026; Chandel, N. S. Mitochondrial metabolism regulation of T cell-mediated immunity. <italic>Annu. Rev. Immunol.</italic><bold>39</bold>, 395&#x02013;416 (2021).<pub-id pub-id-type="pmid">33902315</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Velarde</surname><given-names>MC</given-names></name><name><surname>Flynn</surname><given-names>JM</given-names></name><name><surname>Day</surname><given-names>NU</given-names></name><name><surname>Melov</surname><given-names>S</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name></person-group><article-title>Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin</article-title><source>Aging</source><year>2012</year><volume>4</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.18632/aging.100423</pub-id><pub-id pub-id-type="pmid">22278880</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Velarde, M. C., Flynn, J. M., Day, N. U., Melov, S. &#x00026; Campisi, J. Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin. <italic>Aging</italic><bold>4</bold>, 3&#x02013;12 (2012).<pub-id pub-id-type="pmid">22278880</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Wiley</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Mitochondrial dysfunction induces senescence with a distinct secretory phenotype</article-title><source>Cell Metab.</source><year>2016</year><volume>23</volume><fpage>303</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.11.011</pub-id><pub-id pub-id-type="pmid">26686024</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Wiley, C. D. et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. <italic>Cell Metab.</italic><bold>23</bold>, 303&#x02013;314 (2016).<pub-id pub-id-type="pmid">26686024</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Michalek</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4<sup>+</sup> T cell subsets</article-title><source>J. Immunol.</source><year>2011</year><volume>186</volume><fpage>3299</fpage><lpage>3303</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1003613</pub-id><pub-id pub-id-type="pmid">21317389</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Michalek, R. D. et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4<sup>+</sup> T cell subsets. <italic>J. Immunol.</italic><bold>186</bold>, 3299&#x02013;3303 (2011).<pub-id pub-id-type="pmid">21317389</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>NM</given-names></name><etal/></person-group><article-title>mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>2095</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-04392-5</pub-id><pub-id pub-id-type="pmid">29844370</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Chapman, N. M. et al. mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis. <italic>Nat. Commun.</italic><bold>9</bold>, 2095 (2018).<pub-id pub-id-type="pmid">29844370</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberg</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Mitochondrial complex III is essential for suppressive function of regulatory T cells</article-title><source>Nature</source><year>2019</year><volume>565</volume><fpage>495</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0846-z</pub-id><pub-id pub-id-type="pmid">30626970</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Weinberg, S. E. et al. Mitochondrial complex III is essential for suppressive function of regulatory T cells. <italic>Nature</italic><bold>565</bold>, 495&#x02013;499 (2019).<pub-id pub-id-type="pmid">30626970</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Venditti</surname><given-names>P</given-names></name><name><surname>Di Stefano</surname><given-names>L</given-names></name><name><surname>Di Meo</surname><given-names>S</given-names></name></person-group><article-title>Mitochondrial metabolism of reactive oxygen species</article-title><source>Mitochondrion</source><year>2013</year><volume>13</volume><fpage>71</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.mito.2013.01.008</pub-id><pub-id pub-id-type="pmid">23376030</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Venditti, P., Di Stefano, L. &#x00026; Di Meo, S. Mitochondrial metabolism of reactive oxygen species. <italic>Mitochondrion</italic><bold>13</bold>, 71&#x02013;82 (2013).<pub-id pub-id-type="pmid">23376030</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Mittelbrunn</surname><given-names>M</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Hallmarks of T cell aging</article-title><source>Nat. Immunol.</source><year>2021</year><volume>22</volume><fpage>687</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1038/s41590-021-00927-z</pub-id><pub-id pub-id-type="pmid">33986548</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Mittelbrunn, M. &#x00026; Kroemer, G. Hallmarks of T cell aging. <italic>Nat. Immunol.</italic><bold>22</bold>, 687&#x02013;698 (2021).<pub-id pub-id-type="pmid">33986548</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Mogilenko</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Comprehensive profiling of an aging immune system reveals clonal GZMK<sup>+</sup> CD8<sup>+</sup> T cells as conserved hallmark of inflammaging</article-title><source>Immunity</source><year>2021</year><volume>54</volume><fpage>99</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2020.11.005</pub-id><pub-id pub-id-type="pmid">33271118</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Mogilenko, D. A. et al. Comprehensive profiling of an aging immune system reveals clonal GZMK<sup>+</sup> CD8<sup>+</sup> T cells as conserved hallmark of inflammaging. <italic>Immunity</italic><bold>54</bold>, 99&#x02013;115 (2021).<pub-id pub-id-type="pmid">33271118</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>MA</given-names></name><name><surname>Wan</surname><given-names>YY</given-names></name></person-group><article-title>An essential role of the transcription factor GATA-3 for the function of regulatory T cells</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>337</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.08.012</pub-id><pub-id pub-id-type="pmid">21924928</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Wang, Y., Su, M. A. &#x00026; Wan, Y. Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. <italic>Immunity</italic><bold>35</bold>, 337&#x02013;348 (2011).<pub-id pub-id-type="pmid">21924928</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Wohlfert</surname><given-names>EA</given-names></name><etal/></person-group><article-title>GATA3 controls Foxp3<sup>+</sup> regulatory T cell fate during inflammation in mice</article-title><source>J. Clin. Invest.</source><year>2011</year><volume>121</volume><fpage>4503</fpage><lpage>4515</lpage><pub-id pub-id-type="doi">10.1172/JCI57456</pub-id><pub-id pub-id-type="pmid">21965331</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Wohlfert, E. A. et al. GATA3 controls Foxp3<sup>+</sup> regulatory T cell fate during inflammation in mice. <italic>J. Clin. Invest.</italic><bold>121</bold>, 4503&#x02013;4515 (2011).<pub-id pub-id-type="pmid">21965331</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Schiering</surname><given-names>C</given-names></name><etal/></person-group><article-title>The alarmin IL-33 promotes regulatory T-cell function in the intestine</article-title><source>Nature</source><year>2014</year><volume>513</volume><fpage>564</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1038/nature13577</pub-id><pub-id pub-id-type="pmid">25043027</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. <italic>Nature</italic><bold>513</bold>, 564&#x02013;568 (2014).<pub-id pub-id-type="pmid">25043027</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Siede</surname><given-names>J</given-names></name><etal/></person-group><article-title>IL-33 receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGF&#x003b2; release</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>e0161507</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0161507</pub-id><pub-id pub-id-type="pmid">27548066</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Siede, J. et al. IL-33 receptor-expressing regulatory T cells are highly activated, Th2 biased and suppress CD4 T cell proliferation through IL-10 and TGF&#x003b2; release. <italic>PLoS ONE</italic><bold>11</bold>, e0161507 (2016).<pub-id pub-id-type="pmid">27548066</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Boyman</surname><given-names>O</given-names></name><name><surname>Kovar</surname><given-names>M</given-names></name><name><surname>Rubinstein</surname><given-names>MP</given-names></name><name><surname>Surh</surname><given-names>CD</given-names></name><name><surname>Sprent</surname><given-names>J</given-names></name></person-group><article-title>Selective stimulation of T cell subsets with antibody-cytokine immune complexes</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>1924</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1126/science.1122927</pub-id><pub-id pub-id-type="pmid">16484453</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D. &#x00026; Sprent, J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. <italic>Science</italic><bold>311</bold>, 1924&#x02013;1927 (2006).<pub-id pub-id-type="pmid">16484453</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><etal/></person-group><article-title>Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells</article-title><source>Aging Cell</source><year>2012</year><volume>11</volume><fpage>509</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2012.00812.x</pub-id><pub-id pub-id-type="pmid">22372596</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Sun, L. et al. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells. <italic>Aging Cell</italic><bold>11</bold>, 509&#x02013;519 (2012).<pub-id pub-id-type="pmid">22372596</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Aging is associated with increased regulatory T-cell function</article-title><source>Aging Cell</source><year>2014</year><volume>13</volume><fpage>441</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1111/acel.12191</pub-id><pub-id pub-id-type="pmid">24325345</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Garg, S. K. et al. Aging is associated with increased regulatory T-cell function. <italic>Aging Cell</italic><bold>13</bold>, 441&#x02013;448 (2014).<pub-id pub-id-type="pmid">24325345</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Changes of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> regulatory T cells in aged Balb/c mice</article-title><source>J. Leukoc. Biol.</source><year>2007</year><volume>81</volume><fpage>1386</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1189/jlb.0506364</pub-id><pub-id pub-id-type="pmid">17369496</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Zhao, L. et al. Changes of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> regulatory T cells in aged Balb/c mice. <italic>J. Leukoc. Biol.</italic><bold>81</bold>, 1386&#x02013;1394 (2007).<pub-id pub-id-type="pmid">17369496</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>K-A</given-names></name><name><surname>Kim</surname><given-names>H-R</given-names></name><name><surname>Kang</surname><given-names>I</given-names></name></person-group><article-title>Aging and human CD4<sup>+</sup> regulatory T cells</article-title><source>Mech. Ageing Dev.</source><year>2009</year><volume>130</volume><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2009.06.003</pub-id><pub-id pub-id-type="pmid">19540259</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Hwang, K.-A., Kim, H.-R. &#x00026; Kang, I. Aging and human CD4<sup>+</sup> regulatory T cells. <italic>Mech. Ageing Dev.</italic><bold>130</bold>, 509&#x02013;517 (2009).<pub-id pub-id-type="pmid">19540259</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Delacher</surname><given-names>M</given-names></name><etal/></person-group><article-title>Precursors for nonlymphoid-tissue Treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF</article-title><source>Immunity</source><year>2020</year><volume>52</volume><fpage>295</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.12.002</pub-id><pub-id pub-id-type="pmid">31924477</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Delacher, M. et al. Precursors for nonlymphoid-tissue Treg cells reside in secondary lymphoid organs and are programmed by the transcription factor BATF. <italic>Immunity</italic><bold>52</bold>, 295&#x02013;312 (2020).<pub-id pub-id-type="pmid">31924477</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Beppu</surname><given-names>LY</given-names></name><etal/></person-group><article-title>Tregs facilitate obesity and insulin resistance via a Blimp-1/IL-10 axis</article-title><source>JCI Insight</source><year>2021</year><volume>6</volume><fpage>e140644</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.140644</pub-id><pub-id pub-id-type="pmid">33351782</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Beppu, L. Y. et al. Tregs facilitate obesity and insulin resistance via a Blimp-1/IL-10 axis. <italic>JCI Insight</italic><bold>6</bold>, e140644 (2021).<pub-id pub-id-type="pmid">33351782</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Tauro</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Geiger</surname><given-names>TL</given-names></name></person-group><article-title>Diversification and senescence of Foxp3<sup>+</sup> regulatory T cells during experimental autoimmune encephalomyelitis</article-title><source>Eur. J. Immunol.</source><year>2013</year><volume>43</volume><fpage>1195</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1002/eji.201242881</pub-id><pub-id pub-id-type="pmid">23436224</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Tauro, S., Nguyen, P., Li, B. &#x00026; Geiger, T. L. Diversification and senescence of Foxp3<sup>+</sup> regulatory T cells during experimental autoimmune encephalomyelitis. <italic>Eur. J. Immunol.</italic><bold>43</bold>, 1195&#x02013;1207 (2013).<pub-id pub-id-type="pmid">23436224</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Hadis</surname><given-names>U</given-names></name><etal/></person-group><article-title>Intestinal tolerance requires gut homing and expansion of FoxP3<sup>+</sup> regulatory T cells in the lamina propria</article-title><source>Immunity</source><year>2011</year><volume>34</volume><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.01.016</pub-id><pub-id pub-id-type="pmid">21333554</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Hadis, U. et al. Intestinal tolerance requires gut homing and expansion of FoxP3<sup>+</sup> regulatory T cells in the lamina propria. <italic>Immunity</italic><bold>34</bold>, 237&#x02013;246 (2011).<pub-id pub-id-type="pmid">21333554</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Cebula</surname><given-names>A</given-names></name><etal/></person-group><article-title>Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota</article-title><source>Nature</source><year>2013</year><volume>497</volume><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1038/nature12079</pub-id><pub-id pub-id-type="pmid">23624374</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Cebula, A. et al. Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. <italic>Nature</italic><bold>497</bold>, 258&#x02013;262 (2013).<pub-id pub-id-type="pmid">23624374</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>H</given-names></name><name><surname>Kaur</surname><given-names>G</given-names></name><name><surname>Ali</surname><given-names>SA</given-names></name></person-group><article-title>IL-33&#x02019;s role in the gut immune system: a comprehensive review of its crosstalk and regulation</article-title><source>Life Sci.</source><year>2023</year><volume>327</volume><fpage>121868</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2023.121868</pub-id><pub-id pub-id-type="pmid">37330043</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Kaur, H., Kaur, G. &#x00026; Ali, S. A. IL-33&#x02019;s role in the gut immune system: a comprehensive review of its crosstalk and regulation. <italic>Life Sci.</italic><bold>327</bold>, 121868 (2023).<pub-id pub-id-type="pmid">37330043</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>EL</given-names></name><etal/></person-group><article-title>IL-33 causes thermogenic failure in aging by expanding dysfunctional adipose ILC2</article-title><source>Cell Metab.</source><year>2021</year><volume>33</volume><fpage>2277</fpage><lpage>2287</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.08.004</pub-id><pub-id pub-id-type="pmid">34473956</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Goldberg, E. L. et al. IL-33 causes thermogenic failure in aging by expanding dysfunctional adipose ILC2. <italic>Cell Metab.</italic><bold>33</bold>, 2277&#x02013;2287 (2021).<pub-id pub-id-type="pmid">34473956</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name><etal/></person-group><article-title>IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection</article-title><source>Nat. Commun.</source><year>2022</year><volume>13</volume><fpage>6881</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-34660-4</pub-id><pub-id pub-id-type="pmid">36371464</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Xu, L. et al. IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection. <italic>Nat. Commun.</italic><bold>13</bold>, 6881 (2022).<pub-id pub-id-type="pmid">36371464</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Monzel</surname><given-names>AS</given-names></name><name><surname>Enr&#x000ed;quez</surname><given-names>JA</given-names></name><name><surname>Picard</surname><given-names>M</given-names></name></person-group><article-title>Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction</article-title><source>Nat. Metab.</source><year>2023</year><volume>5</volume><fpage>546</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1038/s42255-023-00783-1</pub-id><pub-id pub-id-type="pmid">37100996</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Monzel, A. S., Enr&#x000ed;quez, J. A. &#x00026; Picard, M. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. <italic>Nat. Metab.</italic><bold>5</bold>, 546&#x02013;562 (2023).<pub-id pub-id-type="pmid">37100996</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y-R</given-names></name><etal/></person-group><article-title>Disturbed mitochondrial dynamics in CD8<sup>+</sup> TILs reinforce T cell exhaustion</article-title><source>Nat. Immunol.</source><year>2020</year><volume>21</volume><fpage>1540</fpage><lpage>1551</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0793-3</pub-id><pub-id pub-id-type="pmid">33020660</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Yu, Y.-R. et al. Disturbed mitochondrial dynamics in CD8<sup>+</sup> TILs reinforce T cell exhaustion. <italic>Nat. Immunol.</italic><bold>21</bold>, 1540&#x02013;1551 (2020).<pub-id pub-id-type="pmid">33020660</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>L</given-names></name><name><surname>de</surname><given-names>B</given-names></name><name><surname>Davanzo</surname><given-names>GG</given-names></name><name><surname>de Aguiar</surname><given-names>CF</given-names></name><name><surname>Moraes-Vieira</surname><given-names>PMM</given-names></name></person-group><article-title>Using flow cytometry for mitochondrial assays</article-title><source>MethodsX</source><year>2020</year><volume>7</volume><fpage>100938</fpage><pub-id pub-id-type="doi">10.1016/j.mex.2020.100938</pub-id><pub-id pub-id-type="pmid">32551241</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Monteiro, L., de, B., Davanzo, G. G., de Aguiar, C. F. &#x00026; Moraes-Vieira, P. M. M. Using flow cytometry for mitochondrial assays. <italic>MethodsX</italic><bold>7</bold>, 100938 (2020).<pub-id pub-id-type="pmid">32551241</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Montes de Oca</surname><given-names>M</given-names></name><etal/></person-group><article-title>IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection</article-title><source>PLoS Pathog.</source><year>2020</year><volume>16</volume><fpage>e1008994</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1008994</pub-id><pub-id pub-id-type="pmid">33049000</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Montes de Oca, M. et al. IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection. <italic>PLoS Pathog.</italic><bold>16</bold>, e1008994 (2020).<pub-id pub-id-type="pmid">33049000</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P-M</given-names></name><etal/></person-group><article-title>CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy</article-title><source>Sci. Adv.</source><year>2022</year><volume>8</volume><fpage>eabo4271</fpage><pub-id pub-id-type="doi">10.1126/sciadv.abo4271</pub-id><pub-id pub-id-type="pmid">35704572</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Chen, P.-M. et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. <italic>Sci. Adv.</italic><bold>8</bold>, eabo4271 (2022).<pub-id pub-id-type="pmid">35704572</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Konjar</surname><given-names>&#x00160;</given-names></name><etal/></person-group><article-title>Mitochondria maintain controlled activation state of epithelial-resident T lymphocytes</article-title><source>Sci. Immunol.</source><year>2018</year><volume>3</volume><fpage>eaan2543</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aan2543</pub-id><pub-id pub-id-type="pmid">29934344</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Konjar, &#x00160;. et al. Mitochondria maintain controlled activation state of epithelial-resident T lymphocytes. <italic>Sci. Immunol.</italic><bold>3</bold>, eaan2543 (2018).<pub-id pub-id-type="pmid">29934344</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Kowaltowski</surname><given-names>AJ</given-names></name><name><surname>Abdulkader</surname><given-names>F</given-names></name></person-group><article-title>How and when to measure mitochondrial inner membrane potentials</article-title><source>Biophys. J.</source><year>2024</year><volume>123</volume><fpage>4150</fpage><lpage>4157</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2024.03.011</pub-id><pub-id pub-id-type="pmid">38454598</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Kowaltowski, A. J. &#x00026; Abdulkader, F. How and when to measure mitochondrial inner membrane potentials. <italic>Biophys. J.</italic><bold>123</bold>, 4150&#x02013;4157 (2024).<pub-id pub-id-type="pmid">38454598</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>C</given-names></name><etal/></person-group><article-title>A T<sub>reg</sub>-specific long noncoding RNA maintains immune-metabolic homeostasis in aging liver</article-title><source>Nat. Aging</source><year>2023</year><volume>3</volume><fpage>813</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1038/s43587-023-00428-8</pub-id><pub-id pub-id-type="pmid">37277640</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Ding, C. et al. A T<sub>reg</sub>-specific long noncoding RNA maintains immune-metabolic homeostasis in aging liver. <italic>Nat. Aging</italic><bold>3</bold>, 813&#x02013;828 (2023).<pub-id pub-id-type="pmid">37277640</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Z</given-names></name><etal/></person-group><article-title>DCAF1 regulates Treg senescence via the ROS axis during immunological aging</article-title><source>J. Clin. Invest.</source><year>2020</year><volume>130</volume><fpage>5893</fpage><lpage>5908</lpage><pub-id pub-id-type="doi">10.1172/JCI136466</pub-id><pub-id pub-id-type="pmid">32730228</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Guo, Z. et al. DCAF1 regulates Treg senescence via the ROS axis during immunological aging. <italic>J. Clin. Invest.</italic><bold>130</bold>, 5893&#x02013;5908 (2020).<pub-id pub-id-type="pmid">32730228</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name></person-group><article-title>cGAS&#x02013;STING signaling</article-title><source>Curr. Biol.</source><year>2022</year><volume>32</volume><fpage>R730</fpage><lpage>R734</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2022.05.027</pub-id><pub-id pub-id-type="pmid">35820380</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Sun, Z. &#x00026; Hornung, V. cGAS&#x02013;STING signaling. <italic>Curr. Biol.</italic><bold>32</bold>, R730&#x02013;R734 (2022).<pub-id pub-id-type="pmid">35820380</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Cytoplasmic chromatin triggers inflammation in senescence and cancer</article-title><source>Nature</source><year>2017</year><volume>550</volume><fpage>402</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1038/nature24050</pub-id><pub-id pub-id-type="pmid">28976970</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. <italic>Nature</italic><bold>550</bold>, 402&#x02013;406 (2017).<pub-id pub-id-type="pmid">28976970</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Linder</surname><given-names>A</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name></person-group><article-title>Inflammasomes in T cells</article-title><source>J. Mol. Biol.</source><year>2022</year><volume>434</volume><fpage>167275</fpage><pub-id pub-id-type="doi">10.1016/j.jmb.2021.167275</pub-id><pub-id pub-id-type="pmid">34599941</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Linder, A. &#x00026; Hornung, V. Inflammasomes in T cells. <italic>J. Mol. Biol.</italic><bold>434</bold>, 167275 (2022).<pub-id pub-id-type="pmid">34599941</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Baixauli</surname><given-names>F</given-names></name><etal/></person-group><article-title>Mitochondrial respiration controls lysosomal function during inflammatory T cell responses</article-title><source>Cell Metab.</source><year>2015</year><volume>22</volume><fpage>485</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.07.020</pub-id><pub-id pub-id-type="pmid">26299452</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Baixauli, F. et al. Mitochondrial respiration controls lysosomal function during inflammatory T cell responses. <italic>Cell Metab.</italic><bold>22</bold>, 485&#x02013;498 (2015).<pub-id pub-id-type="pmid">26299452</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Milanovic</surname><given-names>M</given-names></name><etal/></person-group><article-title>Senescence-associated reprogramming promotes cancer stemness</article-title><source>Nature</source><year>2018</year><volume>553</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/nature25167</pub-id><pub-id pub-id-type="pmid">29258294</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Milanovic, M. et al. Senescence-associated reprogramming promotes cancer stemness. <italic>Nature</italic><bold>553</bold>, 96&#x02013;100 (2018).<pub-id pub-id-type="pmid">29258294</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Salinas-Saavedra</surname><given-names>M</given-names></name><etal/></person-group><article-title>Senescence-induced cellular reprogramming drives cnidarian whole-body regeneration</article-title><source>Cell Rep.</source><year>2023</year><volume>42</volume><fpage>112687</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112687</pub-id><pub-id pub-id-type="pmid">37392741</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Salinas-Saavedra, M. et al. Senescence-induced cellular reprogramming drives cnidarian whole-body regeneration. <italic>Cell Rep.</italic><bold>42</bold>, 112687 (2023).<pub-id pub-id-type="pmid">37392741</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>OT</given-names></name><etal/></person-group><article-title>The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program</article-title><source>Immunity</source><year>2024</year><volume>57</volume><fpage>1586</fpage><lpage>1602</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2024.05.023</pub-id><pub-id pub-id-type="pmid">38897202</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Burton, O. T. et al. The tissue-resident regulatory T cell pool is shaped by transient multi-tissue migration and a conserved residency program. <italic>Immunity</italic><bold>57</bold>, 1586&#x02013;1602 (2024).<pub-id pub-id-type="pmid">38897202</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Correia-Melo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Mitochondria are required for pro-ageing features of the senescent phenotype</article-title><source>EMBO J.</source><year>2016</year><volume>35</volume><fpage>724</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.15252/embj.201592862</pub-id><pub-id pub-id-type="pmid">26848154</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Correia-Melo, C. et al. Mitochondria are required for pro-ageing features of the senescent phenotype. <italic>EMBO J.</italic><bold>35</bold>, 724&#x02013;742 (2016).<pub-id pub-id-type="pmid">26848154</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Vardhana</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen</article-title><source>Nat. Immunol.</source><year>2020</year><volume>21</volume><fpage>1022</fpage><lpage>1033</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0725-2</pub-id><pub-id pub-id-type="pmid">32661364</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Vardhana, S. A. et al. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. <italic>Nat. Immunol.</italic><bold>21</bold>, 1022&#x02013;1033 (2020).<pub-id pub-id-type="pmid">32661364</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Scharping</surname><given-names>NE</given-names></name><etal/></person-group><article-title>Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion</article-title><source>Nat. Immunol.</source><year>2021</year><volume>22</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-00834-9</pub-id><pub-id pub-id-type="pmid">33398183</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Scharping, N. E. et al. Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. <italic>Nat. Immunol.</italic><bold>22</bold>, 205&#x02013;215 (2021).<pub-id pub-id-type="pmid">33398183</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Valle-Noguera</surname><given-names>A</given-names></name><name><surname>G&#x000f3;mez-S&#x000e1;nchez</surname><given-names>MJ</given-names></name><name><surname>Girard-Madoux</surname><given-names>MJH</given-names></name><name><surname>Cruz-Adalia</surname><given-names>A</given-names></name></person-group><article-title>Optimized protocol for characterization of mouse gut innate lymphoid cells</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><fpage>563414</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.563414</pub-id><pub-id pub-id-type="pmid">33329525</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Valle-Noguera, A., G&#x000f3;mez-S&#x000e1;nchez, M. J., Girard-Madoux, M. J. H. &#x00026; Cruz-Adalia, A. Optimized protocol for characterization of mouse gut innate lymphoid cells. <italic>Front. Immunol.</italic><bold>11</bold>, 563414 (2020).<pub-id pub-id-type="pmid">33329525</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>